{
    "paper_id": "PMC7097196",
    "metadata": {
        "title": "Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets",
        "authors": [
            {
                "first": "Fan",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jianmin",
                "middle": [],
                "last": "Yang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yongtao",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mei",
                "middle": [],
                "last": "Dong",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Shuangxi",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Qunye",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Fang",
                "middle": [
                    "Fang"
                ],
                "last": "Liu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Kai",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Cheng",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": "zhangc@sdu.edu.cn",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The importance of the renin\u2013angiotensin system (RAS) in the regulation of normal physiology and pathogenesis of cardiovascular disease is well established.1,2,3,4 The best-known components of the RAS include angiotensinogen, angiotensin I and II, and the peptidases renin and angiotensin-converting enzyme (ACE). Renin is the rate-limiting enzyme in the RAS, whereas angiotensin II is the major effector molecule, which exerts its biological actions via the type-1 angiotensin II (AT1) and type-2 angiotensin II (AT2) receptors. Angiotensin II is generated in the circulation and within tissues (local RAS).1,3,5,6 RAS is implicated in the pathogenesis of various cardiovascular disorders, including hypertension, atherosclerosis, myocardial infarction, pathological cardiac remodelling, heart failure, and metabolic syndrome.1,2,4 ACE2 and its product angiotensin 1\u20137 were identified more recently than the aforementioned components of this system, and are thought to have counteracting effects against the adverse actions of these other RAS components (Figure 1),7 although their physiological and pathophysiological roles are incompletely understood. Findings from numerous experimental studies have suggested notable protective effects in the heart, blood vessels, kidney, and central nervous system. ACE2 and angiotensin 1\u20137 might, therefore, represent new therapeutic targets for cardiovascular disease.7 In this Review, we summarize the evidence from experimental and clinical studies of the effects of ACE2 and angiotensin 1\u20137 in various pathological cardiovascular conditions.",
            "cite_spans": [
                {
                    "start": 155,
                    "end": 156,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 157,
                    "end": 158,
                    "mention": "2",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 159,
                    "end": 160,
                    "mention": "3",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 161,
                    "end": 162,
                    "mention": "4",
                    "ref_id": "BIBREF152"
                },
                {
                    "start": 607,
                    "end": 608,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 609,
                    "end": 610,
                    "mention": "3",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 611,
                    "end": 612,
                    "mention": "5",
                    "ref_id": "BIBREF163"
                },
                {
                    "start": 613,
                    "end": 614,
                    "mention": "6",
                    "ref_id": "BIBREF174"
                },
                {
                    "start": 826,
                    "end": 827,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 828,
                    "end": 829,
                    "mention": "2",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 830,
                    "end": 831,
                    "mention": "4",
                    "ref_id": "BIBREF152"
                },
                {
                    "start": 1065,
                    "end": 1066,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 1409,
                    "end": 1410,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 1055,
                    "end": 1063,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "ACE2 (also known as ACE-related carboxypeptidase, angiotensin-converting enzyme homologue, or ACEH) is a monocarboxypeptidase that is mainly expressed in vascular endothelial cells and the renal tubular epithelium.8 The gene for ACE2 was cloned in 2000 by two independent groups as a homologue of human ACE.8,9 The ACE2 protein is an 805 amino-acid type-I transmembrane protein that contains an extracellular (ecto) domain (amino acids 18\u2013739), a transmembrane region (amino acids 740\u2013768), and an intracellular tail. The extracellular part of ACE2 (Figure 2) contains the catalytic domain (amino acids 147\u2013555), which has a substrate binding region (amino acids 273\u2013345) and a typical HEMGH metalloproteinase zinc-binding site (amino acids 374\u2013378).8,10,11,12,13 The C-terminal part of ACE2 (614\u2013805) is homologous (48% identity) to a transporter protein known as collectrin.11,14 The catalytic domain of ACE2 is 42% identical to that of ACE.8",
            "cite_spans": [
                {
                    "start": 214,
                    "end": 215,
                    "mention": "8",
                    "ref_id": "BIBREF196"
                },
                {
                    "start": 307,
                    "end": 308,
                    "mention": "8",
                    "ref_id": "BIBREF196"
                },
                {
                    "start": 309,
                    "end": 310,
                    "mention": "9",
                    "ref_id": "BIBREF207"
                },
                {
                    "start": 750,
                    "end": 751,
                    "mention": "8",
                    "ref_id": "BIBREF196"
                },
                {
                    "start": 752,
                    "end": 754,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 755,
                    "end": 757,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 758,
                    "end": 760,
                    "mention": "12",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 761,
                    "end": 763,
                    "mention": "13",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 876,
                    "end": 878,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 879,
                    "end": 881,
                    "mention": "14",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 943,
                    "end": 944,
                    "mention": "8",
                    "ref_id": "BIBREF196"
                }
            ],
            "section": "Biochemical characteristics ::: Properties of ACE2",
            "ref_spans": [
                {
                    "start": 550,
                    "end": 558,
                    "mention": "Figure 2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "The peptidase activity of ACE2 is dependent on the C-terminus sequence of the substrate (sequence specificity). ACE2 substrates generally have a hydrophobic or basic residue at the C-terminal end, preceded by a Pro-X-Pro motif, where either one of the two proline residues is sufficient to allow ACE2-dependent hydrolysis.15 In this circumstance, ACE2 displays potent peptidase activity to angiotensin II (Pro-Phe), angiotensin I (Pro-Phe-His-Leu), and des-Arg9 bradykinin (Ser-Pro-Phe), but shows no activity towards angiotensin 1\u20139, angiotensin 1\u20137, or bradykinin.16 ACE2 can also hydrolyse other bioactive peptides, such as apelin-13, \u03b2-casomorphin, dynorphin A 1\u201313, and ghrelin.16 The most-important active product of ACE2 is angiotensin 1\u20137, which can be primarily generated via two routes. First, ACE2 can directly hydrolyse angiotensin II to yield angiotensin 1\u20137; second, ACE2 can convert angiotensin I to angiotensin 1\u20139, which is then cleaved by either neutral endopeptidase (NEP) or ACE to yield angiotensin 1\u20137.12,17,18 In addition, angiotensin 1\u20137 can be produced by prolyl carboxypeptidase from angiotensin II or by NEP directly from angiotensin I.18 The biological functions of angiotensin 1\u20139 are poorly understood, although important effects in the cardiovascular system have been purported.19,20 The affinity of ACE2 to angiotensin II (Km = 2.0 \u03bcmol/l, which represents the concentration of substrate required for the enzyme to achieve half maximum catalytic velocity; that is, the higher the Km value, the lower the affinity) is higher than to angiotensin I (Km = 6.9 \u03bcmol/l). The ACE2 catalytic efficiency for angiotensin II is >300 times that for angiotensin I.16 The angiotensin I\u2013ACE\u2013angiotensin II\u2013ACE2\u2013angiotensin 1\u20137 pathway (Figure 1) ought, therefore, to have a predominant role in the production of angiotensin 1\u20137 in vivo.",
            "cite_spans": [
                {
                    "start": 322,
                    "end": 324,
                    "mention": "15",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 460,
                    "end": 461,
                    "mention": "9",
                    "ref_id": "BIBREF207"
                },
                {
                    "start": 566,
                    "end": 568,
                    "mention": "16",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 683,
                    "end": 685,
                    "mention": "16",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 1024,
                    "end": 1026,
                    "mention": "12",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 1027,
                    "end": 1029,
                    "mention": "17",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 1030,
                    "end": 1032,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 1163,
                    "end": 1165,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 1309,
                    "end": 1311,
                    "mention": "19",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 1312,
                    "end": 1314,
                    "mention": "20",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 1683,
                    "end": 1685,
                    "mention": "16",
                    "ref_id": "BIBREF67"
                }
            ],
            "section": "Biochemical characteristics ::: Properties of ACE2",
            "ref_spans": [
                {
                    "start": 1753,
                    "end": 1761,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "The membrane-bound ectodomain of ACE2 can be cleaved by the metalloproteinase ADAM17, which releases a soluble form of ACE2 (Figure 1).21,22 By use of serial deletion constructs of ACE2, Iwata and colleagues identified a juxtamembrane region (amino acids 720\u2013729) that is essential for ADAM17-mediated ectodomain shedding.23 The physiological relevance of soluble ACE2 is not fully understood. Its activity in plasma is raised in patients with chronic heart failure23 and is associated with increased cardiac dysfunction and poor clinical outcomes.24 Moreover, soluble ACE2 activity is raised after myocardial infarction, which has been associated with an increased incidence of subsequent adverse left ventricular remodelling.25 Findings from one study suggested that angiotensin II promotes ACE2 shedding by increasing ADAM17 activity in the myocardium. This action represents a positive feedback mechanism by which angiotensin II facilitates myocardial injury.26",
            "cite_spans": [
                {
                    "start": 135,
                    "end": 137,
                    "mention": "21",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 138,
                    "end": 140,
                    "mention": "22",
                    "ref_id": "BIBREF133"
                },
                {
                    "start": 322,
                    "end": 324,
                    "mention": "23",
                    "ref_id": "BIBREF134"
                },
                {
                    "start": 465,
                    "end": 467,
                    "mention": "23",
                    "ref_id": "BIBREF134"
                },
                {
                    "start": 548,
                    "end": 550,
                    "mention": "24",
                    "ref_id": "BIBREF135"
                },
                {
                    "start": 727,
                    "end": 729,
                    "mention": "25",
                    "ref_id": "BIBREF136"
                },
                {
                    "start": 963,
                    "end": 965,
                    "mention": "26",
                    "ref_id": "BIBREF137"
                }
            ],
            "section": "Biochemical characteristics ::: Properties of ACE2",
            "ref_spans": [
                {
                    "start": 125,
                    "end": 133,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Several compounds are known to affect ACE2 activity. MLN-4760 is a specific and potent ACE2 inhibitor with a half maximum inhibitory concentration (IC50) of 0.4 nmol/l.27 X-ray diffraction studies have revealed that the catalytic domain of ACE2 contains two subdomains linked by an \u03b1-helix hinge region, which forms a long and deep cleft. MLN-4760 binds to both of the subdomains (Figure 2) and causes the hinge to flex, which shrinks the cleft and prevents substrate binding.28 ACE2 inhibition in vivo by MLN-4760 aggravated glomerular injury in a model of type 1 diabetes mellitus,29 and exacerbated cardiac hypertrophy and fibrosis in transgenic hypertensive rats.30",
            "cite_spans": [
                {
                    "start": 168,
                    "end": 170,
                    "mention": "27",
                    "ref_id": "BIBREF138"
                },
                {
                    "start": 476,
                    "end": 478,
                    "mention": "28",
                    "ref_id": "BIBREF139"
                },
                {
                    "start": 583,
                    "end": 585,
                    "mention": "29",
                    "ref_id": "BIBREF140"
                },
                {
                    "start": 667,
                    "end": 669,
                    "mention": "30",
                    "ref_id": "BIBREF142"
                }
            ],
            "section": "Pharmacological activators and inhibitors ::: Properties of ACE2",
            "ref_spans": [
                {
                    "start": 381,
                    "end": 389,
                    "mention": "Figure 2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "DX600 is a peptide inhibitor of ACE2 with a high affinity (Kd = 10.8 nmol/l; this value is the equilibrated concentration required to achieve 50% occupancy of the receptors in radioligand binding assays; that is, the higher the Kd value, the lower the affinity) and high efficacy (IC50 = 10.1 nmol/l), but has no obvious inhibitory effect toward ACE.31 In in vitro and in vivo experiments, DX600 has shown antagonistic effects on ACE2-mediated actions.32,33 Kinetic analyses have revealed that DX600 exhibits a mixed competitive and noncompetitive type of inhibition, which indicates that this peptide might act as a partial allosteric modulator of ACE2; this mode of action is analogous to that of some ACE inhibitors, such as captopril.31 Several studies reported that DX600 displayed different efficacy of inhibition for human and rodent ACE2.34,35",
            "cite_spans": [
                {
                    "start": 350,
                    "end": 352,
                    "mention": "31",
                    "ref_id": "BIBREF143"
                },
                {
                    "start": 452,
                    "end": 454,
                    "mention": "32",
                    "ref_id": "BIBREF144"
                },
                {
                    "start": 455,
                    "end": 457,
                    "mention": "33",
                    "ref_id": "BIBREF145"
                },
                {
                    "start": 738,
                    "end": 740,
                    "mention": "31",
                    "ref_id": "BIBREF143"
                },
                {
                    "start": 846,
                    "end": 848,
                    "mention": "34",
                    "ref_id": "BIBREF146"
                },
                {
                    "start": 849,
                    "end": 851,
                    "mention": "35",
                    "ref_id": "BIBREF147"
                }
            ],
            "section": "Pharmacological activators and inhibitors ::: Properties of ACE2",
            "ref_spans": []
        },
        {
            "text": "Given the potential protective roles of ACE2 in the cardiovascular system, identification of novel ACE2 activators is an important avenue for drug discovery. Two small-molecule ACE2 enhancers, xanthenone and resorcinolnaphthalein, have been discovered.36\nIn vitro, these compounds enhanced ACE2 activity by around twofold at concentrations of 100 \u03bcmol/l, but showed no effects on ACE activity. The pharmacological effects of xanthenone were further explored in vivo in healthy, normal rats and spontaneously hypertensive rats (SHRs), and showed remarkable hypotensive and cardiac protective actions.36,37 Potent antithrombotic actions were reported for xanthenone in a rat model of venous thrombosis, whereas DX600 led to opposite effects.33 These beneficial effects should, however, be interpreted with caution, because xanthenone can increase ACE2 expression.37 Indeed, the specificity of xanthenone for ACE2 has been questioned.38",
            "cite_spans": [
                {
                    "start": 252,
                    "end": 254,
                    "mention": "36",
                    "ref_id": "BIBREF148"
                },
                {
                    "start": 599,
                    "end": 601,
                    "mention": "36",
                    "ref_id": "BIBREF148"
                },
                {
                    "start": 602,
                    "end": 604,
                    "mention": "37",
                    "ref_id": "BIBREF149"
                },
                {
                    "start": 739,
                    "end": 741,
                    "mention": "33",
                    "ref_id": "BIBREF145"
                },
                {
                    "start": 861,
                    "end": 863,
                    "mention": "37",
                    "ref_id": "BIBREF149"
                },
                {
                    "start": 931,
                    "end": 933,
                    "mention": "38",
                    "ref_id": "BIBREF150"
                }
            ],
            "section": "Pharmacological activators and inhibitors ::: Properties of ACE2",
            "ref_spans": []
        },
        {
            "text": "In addition to ACE2-dependent routes, angiotensin 1\u20137 can be generated directly from angiotensin I by prolyl endopeptidase and NEP.18 The heart, brain, and kidney are major sources of angiotensin 1\u20137 production.17 In the human coronary circulation, NEP seems to have a more-prominent role in angiotensin 1\u20137 production than ACE2.39 Pharmacokinetic experiments have determined that, in humans, angiotensin 1\u20137 has a short half-life of \u223c0.5 h.40 Following subcutaneous injection, the peptide is quickly available in the blood and reaches its peak plasma concentration at \u223c1 h.40 In rats, the plasma half-life of angiotensin 1\u20137 is only 9 s.41 Angiotensin 1\u20137 is metabolized mainly by ACE in the lungs.42 In addition, aminopeptidase and NEP can degrade angiotensin 1\u20137 into peptide segments.42",
            "cite_spans": [
                {
                    "start": 131,
                    "end": 133,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 211,
                    "end": 213,
                    "mention": "17",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 329,
                    "end": 331,
                    "mention": "39",
                    "ref_id": "BIBREF151"
                },
                {
                    "start": 441,
                    "end": 443,
                    "mention": "40",
                    "ref_id": "BIBREF153"
                },
                {
                    "start": 574,
                    "end": 576,
                    "mention": "40",
                    "ref_id": "BIBREF153"
                },
                {
                    "start": 638,
                    "end": 640,
                    "mention": "41",
                    "ref_id": "BIBREF154"
                },
                {
                    "start": 699,
                    "end": 701,
                    "mention": "42",
                    "ref_id": "BIBREF155"
                },
                {
                    "start": 788,
                    "end": 790,
                    "mention": "42",
                    "ref_id": "BIBREF155"
                }
            ],
            "section": "Biochemical characteristics ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "Angiotensin 1\u20137 has broad effects in the cardiovascular system, including vasodilatation; myocardial protection; antiarrhythmic, antihypertensive, and positive inotropic effects; and inhibition of pathological cardiac remodelling.18,43,44 In addition, angiotensin 1\u20137 is thought to have favourable effects on metabolism by lessening insulin resistance.45,46,47 Although most effects are protective, some seem to be variable. For example, effects on arrhythmia might be biphasic, with high concentrations of angiotensin 1\u20137 promoting cardiac arrhythmias and low concentrations having protective effects.48,49,50 Similarly, some experimental findings suggest that the biological functions of angiotensin 1\u20137 in the kidney might be beneficial (diuretic or natriuretic, antifibrotic, and antiproliferative), whereas other findings suggest they are detrimental (antidiuretic, proinflammatory, and profibrotic).18,44",
            "cite_spans": [
                {
                    "start": 230,
                    "end": 232,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 233,
                    "end": 235,
                    "mention": "43",
                    "ref_id": "BIBREF156"
                },
                {
                    "start": 236,
                    "end": 238,
                    "mention": "44",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 352,
                    "end": 354,
                    "mention": "45",
                    "ref_id": "BIBREF158"
                },
                {
                    "start": 355,
                    "end": 357,
                    "mention": "46",
                    "ref_id": "BIBREF159"
                },
                {
                    "start": 358,
                    "end": 360,
                    "mention": "47",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 602,
                    "end": 604,
                    "mention": "48",
                    "ref_id": "BIBREF161"
                },
                {
                    "start": 605,
                    "end": 607,
                    "mention": "49",
                    "ref_id": "BIBREF162"
                },
                {
                    "start": 608,
                    "end": 610,
                    "mention": "50",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 905,
                    "end": 907,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 908,
                    "end": 910,
                    "mention": "44",
                    "ref_id": "BIBREF157"
                }
            ],
            "section": "Biochemical characteristics ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "Although the biological actions of angiotensin 1\u20137 are well described, the signalling mechanisms are still poorly understood. Treatment with angiotensin 1\u20137 activates the phosphatidylinositol-3-kinase\u2013Akt pathway in vitro51,52,53,54 and in vivo.45,55 This action could at least partly explain the beneficial effects of angiotensin 1\u20137 on blood vessel functions and metabolism, given the pivotal roles of Akt in promoting endothelial nitric oxide synthase function and insulin signalling.18 By contrast, angiotensin 1\u20137 has inhibitory effects on activated mitogen-activated protein kinase (MAPK) pathways in endothelial cells,56 smooth-muscle cells,57,58 cardiac myocytes,59 and renal proximal tubular cells.60 In these cells, angiotensin II induces oxidative, hypertrophic, and proliferative responses by activating MAPKs and, therefore, angiotensin 1\u20137 might counter-regulate these effects. The effects of angiotensin 1\u20137 on MAPKs, however, are highly cell specific; in some types of cells, angiotensin 1\u20137 augments basal or angiotensin-II-induced MAPK activation.61,62,63 Smooth-muscle depolarization via angiotensin 1\u20137-induced opening of potassium channels has been demonstrated, and seems to be dependent on activation of the cAMP\u2013cAMP-dependent protein kinase (PKA) pathway.64",
            "cite_spans": [
                {
                    "start": 221,
                    "end": 223,
                    "mention": "51",
                    "ref_id": "BIBREF165"
                },
                {
                    "start": 224,
                    "end": 226,
                    "mention": "52",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 227,
                    "end": 229,
                    "mention": "53",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 230,
                    "end": 232,
                    "mention": "54",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 245,
                    "end": 247,
                    "mention": "45",
                    "ref_id": "BIBREF158"
                },
                {
                    "start": 248,
                    "end": 250,
                    "mention": "55",
                    "ref_id": "BIBREF169"
                },
                {
                    "start": 487,
                    "end": 489,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 625,
                    "end": 627,
                    "mention": "56",
                    "ref_id": "BIBREF170"
                },
                {
                    "start": 648,
                    "end": 650,
                    "mention": "57",
                    "ref_id": "BIBREF171"
                },
                {
                    "start": 651,
                    "end": 653,
                    "mention": "58",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 671,
                    "end": 673,
                    "mention": "59",
                    "ref_id": "BIBREF173"
                },
                {
                    "start": 707,
                    "end": 709,
                    "mention": "60",
                    "ref_id": "BIBREF175"
                },
                {
                    "start": 1065,
                    "end": 1067,
                    "mention": "61",
                    "ref_id": "BIBREF176"
                },
                {
                    "start": 1068,
                    "end": 1070,
                    "mention": "62",
                    "ref_id": "BIBREF177"
                },
                {
                    "start": 1071,
                    "end": 1073,
                    "mention": "63",
                    "ref_id": "BIBREF178"
                },
                {
                    "start": 1280,
                    "end": 1282,
                    "mention": "64",
                    "ref_id": "BIBREF179"
                }
            ],
            "section": "Biochemical characteristics ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "Early radioligand-binding studies indicated that angiotensin 1\u20137 could bind to the AT1 receptor in the brain and kidney,65,66 although in a study that used a more-homogenous assay system, virtually no binding was observed in HEK293 cells stably expressing AT1 receptors.67 Angiotensin 1\u20137 binds to the AT2 receptor with a moderate affinity (five times lower than that for angiotensin II).67\nIn vitro68 and in vivo69 studies have demonstrated that certain biological effects of angiotensin 1\u20137 can be attenuated by use of the AT2 receptor antagonist PD123319 and, therefore, angiotensin 1\u20137 binding to AT2 receptors is functionally relevant.",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 122,
                    "mention": "65",
                    "ref_id": "BIBREF180"
                },
                {
                    "start": 123,
                    "end": 125,
                    "mention": "66",
                    "ref_id": "BIBREF181"
                },
                {
                    "start": 270,
                    "end": 272,
                    "mention": "67",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 388,
                    "end": 390,
                    "mention": "67",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 399,
                    "end": 401,
                    "mention": "68",
                    "ref_id": "BIBREF183"
                },
                {
                    "start": 413,
                    "end": 415,
                    "mention": "69",
                    "ref_id": "BIBREF184"
                }
            ],
            "section": "Receptors and their agonists and antagonists ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "The Mas protein, which was originally cloned as an oncogene product,70 is a seven-transmembrane G-protein-coupled receptor with a high affinity for angiotensin 1\u20137 (Kd = 0.83 nmol/l).71 The gene for this protein, MAS1, is mainly expressed in the brain, testis, kidney, and heart.72,73,74,75,76 The expression level of Mas is dynamically regulated by physiological and pathological stimuli in the heart.77 Mas expression is also observed in vascular endothelial cells.53,73,78 Expression of Mas remains to be confirmed in vascular smooth-muscle cells, although angiotensin 1\u20137-induced effects have been readily observed in these cells in various functional experiments.58,79,80\nMas1-knockout animals show cardiovascular-related phenotypes, including myocardial contractile dysfunction, cardiac fibrosis, hypertension, endothelial dysfunction, renal fibrosis, glomerular dysfunction, insulin resistance, and dyslipidaemia.75,81,82,83 However, in two studies in which different models of hypertension (the two-kidney, one-clip model and hypertension induced in response to high salt ingestion) were assessed, Mas deficiency had opposite effects on blood pressure.84,85",
            "cite_spans": [
                {
                    "start": 68,
                    "end": 70,
                    "mention": "70",
                    "ref_id": "BIBREF186"
                },
                {
                    "start": 183,
                    "end": 185,
                    "mention": "71",
                    "ref_id": "BIBREF187"
                },
                {
                    "start": 279,
                    "end": 281,
                    "mention": "72",
                    "ref_id": "BIBREF188"
                },
                {
                    "start": 282,
                    "end": 284,
                    "mention": "73",
                    "ref_id": "BIBREF189"
                },
                {
                    "start": 285,
                    "end": 287,
                    "mention": "74",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 288,
                    "end": 290,
                    "mention": "75",
                    "ref_id": "BIBREF191"
                },
                {
                    "start": 291,
                    "end": 293,
                    "mention": "76",
                    "ref_id": "BIBREF192"
                },
                {
                    "start": 402,
                    "end": 404,
                    "mention": "77",
                    "ref_id": "BIBREF193"
                },
                {
                    "start": 467,
                    "end": 469,
                    "mention": "53",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 470,
                    "end": 472,
                    "mention": "73",
                    "ref_id": "BIBREF189"
                },
                {
                    "start": 473,
                    "end": 475,
                    "mention": "78",
                    "ref_id": "BIBREF194"
                },
                {
                    "start": 668,
                    "end": 670,
                    "mention": "58",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 671,
                    "end": 673,
                    "mention": "79",
                    "ref_id": "BIBREF195"
                },
                {
                    "start": 674,
                    "end": 676,
                    "mention": "80",
                    "ref_id": "BIBREF197"
                },
                {
                    "start": 920,
                    "end": 922,
                    "mention": "75",
                    "ref_id": "BIBREF191"
                },
                {
                    "start": 923,
                    "end": 925,
                    "mention": "81",
                    "ref_id": "BIBREF198"
                },
                {
                    "start": 926,
                    "end": 928,
                    "mention": "82",
                    "ref_id": "BIBREF199"
                },
                {
                    "start": 929,
                    "end": 931,
                    "mention": "83",
                    "ref_id": "BIBREF200"
                },
                {
                    "start": 1160,
                    "end": 1162,
                    "mention": "84",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 1163,
                    "end": 1165,
                    "mention": "85",
                    "ref_id": "BIBREF202"
                }
            ],
            "section": "Receptors and their agonists and antagonists ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "Functional studies have suggested that most cardiovascular effects of angiotensin 1\u20137 are likely to be mediated by Mas.18,86,87,88 The precise angiotensin 1\u20137\u2013Mas signalling mechanisms in the context of cardiovascular physiology have not, however, been firmly established. First, MAS1 is an oncogene, and activation of Mas signalling induces cell transformation via the small GTPase p21-Rac1.89 This effect is not reproduced by angiotensin 1\u20137. Rather, it has some antitumorigenic effects.90,91 Second, Mas is constitutively coupled to G\u03b1q/11 and downstream phospholipase C\u2013protein kinase C signalling.92,93 Evidence indicates, however, that angiotensin 1\u20137 does not stimulate G\u03b1q signalling in Mas-expressing cells.93 Moreover, ectopic expression of Mas induces an increase in the intracellular concentration of Ca2+, whereas angiotensin 1\u20137 treatment does not raise intracellular concentrations of Ca2+.93,94,95 Third, the mechanistic link between Mas and the Akt pathway, which has been implicated in the cardioprotective actions of angiotensin 1\u20137, is still missing.",
            "cite_spans": [
                {
                    "start": 119,
                    "end": 121,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 122,
                    "end": 124,
                    "mention": "86",
                    "ref_id": "BIBREF203"
                },
                {
                    "start": 125,
                    "end": 127,
                    "mention": "87",
                    "ref_id": "BIBREF204"
                },
                {
                    "start": 128,
                    "end": 130,
                    "mention": "88",
                    "ref_id": "BIBREF205"
                },
                {
                    "start": 392,
                    "end": 394,
                    "mention": "89",
                    "ref_id": "BIBREF206"
                },
                {
                    "start": 489,
                    "end": 491,
                    "mention": "90",
                    "ref_id": "BIBREF208"
                },
                {
                    "start": 492,
                    "end": 494,
                    "mention": "91",
                    "ref_id": "BIBREF209"
                },
                {
                    "start": 602,
                    "end": 604,
                    "mention": "92",
                    "ref_id": "BIBREF210"
                },
                {
                    "start": 605,
                    "end": 607,
                    "mention": "93",
                    "ref_id": "BIBREF211"
                },
                {
                    "start": 716,
                    "end": 718,
                    "mention": "93",
                    "ref_id": "BIBREF211"
                },
                {
                    "start": 905,
                    "end": 907,
                    "mention": "93",
                    "ref_id": "BIBREF211"
                },
                {
                    "start": 908,
                    "end": 910,
                    "mention": "94",
                    "ref_id": "BIBREF212"
                },
                {
                    "start": 911,
                    "end": 913,
                    "mention": "95",
                    "ref_id": "BIBREF213"
                }
            ],
            "section": "Receptors and their agonists and antagonists ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "In many circumstances, the effects of angiotensin 1\u20137 are antagonistic to those induced by angiotensin II in the cardiovascular system,18,56,58,96 but the underlying signalling mechanisms remain to be defined. Mas binds directly to the AT1 receptor, but the interaction is unlikely to have a role in mediating angiotensin 1\u20137 effects, since administration of angiotensin 1\u20137 has no effects on this complex.97 Despite the discovery of binding, Mas is still classified as a class A orphan receptor under the latest International Union of Basic and Clinical Pharmacology classification.98",
            "cite_spans": [
                {
                    "start": 135,
                    "end": 137,
                    "mention": "18",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 138,
                    "end": 140,
                    "mention": "56",
                    "ref_id": "BIBREF170"
                },
                {
                    "start": 141,
                    "end": 143,
                    "mention": "58",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 144,
                    "end": 146,
                    "mention": "96",
                    "ref_id": "BIBREF214"
                },
                {
                    "start": 406,
                    "end": 408,
                    "mention": "97",
                    "ref_id": "BIBREF215"
                },
                {
                    "start": 583,
                    "end": 585,
                    "mention": "98",
                    "ref_id": "BIBREF216"
                }
            ],
            "section": "Receptors and their agonists and antagonists ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "The widely used Mas antagonist (D-Ala7)-angiotensin-(1\u20137) is an angiotensin 1\u20137 analogue with the last proline residue substituted with D-Ala.99 This agent is water soluble. Radioligand-binding experiments show that (D-Ala7)-angiotensin-(1\u20137) has a high efficacy in Mas inhibition (IC50 for angiotensin 1\u20137 binding = 0.3 nmol/l).71 By contrast, the binding affinity of (D-Ala7)-angiotensin-(1\u20137) to the AT1 and AT2 receptors is negligible.67,99 A similar peptide Mas antagonist is (D-Pro7)-angiotensin-(1\u20137). The pharmacological properties of this agent have not been fully characterized, but at 10 \u03bcmol/l it exhibits similar effects to (D-Ala7)-angiotensin-(1\u20137) in competing for angiotensin 1\u20137 binding, and showed weak affinities for the AT1 and AT2 receptors.100 Currently, no specific nonpeptide Mas antagonist is available.",
            "cite_spans": [
                {
                    "start": 37,
                    "end": 38,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 142,
                    "end": 144,
                    "mention": "99",
                    "ref_id": "BIBREF217"
                },
                {
                    "start": 222,
                    "end": 223,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 329,
                    "end": 331,
                    "mention": "71",
                    "ref_id": "BIBREF187"
                },
                {
                    "start": 375,
                    "end": 376,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 439,
                    "end": 441,
                    "mention": "67",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 442,
                    "end": 444,
                    "mention": "99",
                    "ref_id": "BIBREF217"
                },
                {
                    "start": 487,
                    "end": 488,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 643,
                    "end": 644,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 763,
                    "end": 766,
                    "mention": "100",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Receptors and their agonists and antagonists ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "AVE 0991 is a small-molecule agonist with high affinity and selectivity for Mas that competes for specific binding of angiotensin 1\u20137. It has an IC50 of \u223c10\u22128 mol/l, and virtually no affinity to the AT1 or AT2 receptors.67,101,102 The maximum stimulating effect of AVE 0991 on release of endothelial nitric oxide is equivalent to that of angiotensin 1\u20137.101",
            "cite_spans": [
                {
                    "start": 220,
                    "end": 222,
                    "mention": "67",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 223,
                    "end": 226,
                    "mention": "101",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 227,
                    "end": 230,
                    "mention": "102",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 354,
                    "end": 357,
                    "mention": "101",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Receptors and their agonists and antagonists ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "CGEN-856S is a 24 amino acid peptide with no obvious homology to angiotensin fragments or other known endogenous GPCR ligands.103 CGEN-856S at 0.1 \u03bcmol/l and 1.0 \u03bcmol/l is equally as potent as angiotensin 1\u20137 for Mas receptor binding. This agent has no binding activity for the AT1 receptor, but it shows a moderate binding affinity for the AT2 receptor (IC50 \u223c5 \u03bcmol/l).103",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 129,
                    "mention": "103",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 371,
                    "end": 374,
                    "mention": "103",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Receptors and their agonists and antagonists ::: Properties of angiotensin 1\u20137",
            "ref_spans": []
        },
        {
            "text": "ACE2 seems to have beneficial effects on the regulation of blood pressure (Table 1; Figure 3). ACE2-deficient C57BL/6 mice have raised basal blood pressure, with notable amplifications of angiotensin-II-induced hypertension, and have increased accumulation of angiotensin II in plasma and the kidney after angiotensin II infusion.104 Gain-of-function experiments in SHRs indicated that ACE2 expression in the central nervous system is associated with substantially decreased blood pressure. For example, overexpression of human ACE2 in the rostral ventrolateral medulla produced long-term hypotensive effects in SHRs.105 Similarly, overexpression of ACE2 in the paraventricular nucleus ameliorated hypertension induced by angiotensin II in healthy, normal rats.106 Moreover, pan-neuronal expression of ACE2 in the brain and delivery of ACE2-expressing adenoviruses into the cerebral ventricle have attenuated high blood pressure and improved baroreflex dysfunction induced by angiotensin II.107,108 In addition to these central actions, targeted expression of human ACE2 in vascular smooth muscle cells decreases blood pressure in stroke-prone SHRs.109",
            "cite_spans": [
                {
                    "start": 330,
                    "end": 333,
                    "mention": "104",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 617,
                    "end": 620,
                    "mention": "105",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 761,
                    "end": 764,
                    "mention": "106",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 991,
                    "end": 994,
                    "mention": "107",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 995,
                    "end": 998,
                    "mention": "108",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1149,
                    "end": 1152,
                    "mention": "109",
                    "ref_id": "BIBREF11"
                }
            ],
            "section": "Blood-pressure regulation",
            "ref_spans": [
                {
                    "start": 84,
                    "end": 92,
                    "mention": "Figure 3",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 75,
                    "end": 82,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Pharmacological intervention studies have revealed similar beneficial effects of ACE2 on high blood pressure. Systemic administration of human recombinant ACE2 counteracted pressor effects induced by angiotensin II, which was associated with accelerated clearance of circulating angiotensin II.110,111 Moreover, in SHRs, chronic ACE2 treatment resulted in a sustained decrease in blood pressure.111 Murine recombinant ACE2 has similar antihypertensive effects to human ACE2 in hypertension induced by angiotensin II.35 Likewise, chronic infusion of the ACE2-activating compound xanthenone slightly decreases blood pressure in SHRs.36",
            "cite_spans": [
                {
                    "start": 294,
                    "end": 297,
                    "mention": "110",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 298,
                    "end": 301,
                    "mention": "111",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 395,
                    "end": 398,
                    "mention": "111",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 516,
                    "end": 518,
                    "mention": "35",
                    "ref_id": "BIBREF147"
                },
                {
                    "start": 631,
                    "end": 633,
                    "mention": "36",
                    "ref_id": "BIBREF148"
                }
            ],
            "section": "Blood-pressure regulation",
            "ref_spans": []
        },
        {
            "text": "In contrast to the reported protective effects of ACE2 in experimental hypertension, studies with angiotensin 1\u20137 have yielded rather heterogeneous results (Table 1). Most of the studies have shown that acute systemic infusion of angiotensin 1\u20137, in either rats with normal blood pressure or those with hypertension due to various aetiologies, does not change blood pressure.112,113,114 Decreases in mean blood pressure in Dahl salt-sensitive rats, however, have been reported.115 In anaesthetized mice, bolus administration of angiotensin 1\u20137 showed no effect on angiotensin-II-induced elevation in blood pressure or on blood-pressure recovery after injected angiotensin II was stopped.110 In healthy, normal rats, acute infusion of angiotensin 1\u20137 led to an enhancement of the hypotensive effects of bradykinin.112,116 Chronic treatment with angiotensin 1\u20137 was associated with transient or sustained reductions in blood pressure in various hypertensive models, including SHRs and Dahl salt-sensitive rats,117,118 but not in deoxycorticosterone-acetate (DOCA) salt-treated rats.119 Results in the two-kidney one-clip model of hypertension in rats have been inconsistent.120,121 Moreover, chronic angiotensin 1\u20137 treatment has been observed to further increase blood pressure in rats with hypertension induced by subtotal nephrectomy.122",
            "cite_spans": [
                {
                    "start": 375,
                    "end": 378,
                    "mention": "112",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 379,
                    "end": 382,
                    "mention": "113",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 383,
                    "end": 386,
                    "mention": "114",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 477,
                    "end": 480,
                    "mention": "115",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 687,
                    "end": 690,
                    "mention": "110",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 813,
                    "end": 816,
                    "mention": "112",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 817,
                    "end": 820,
                    "mention": "116",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1008,
                    "end": 1011,
                    "mention": "117",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1012,
                    "end": 1015,
                    "mention": "118",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1080,
                    "end": 1083,
                    "mention": "119",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1172,
                    "end": 1175,
                    "mention": "120",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 1176,
                    "end": 1179,
                    "mention": "121",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 1335,
                    "end": 1338,
                    "mention": "122",
                    "ref_id": "BIBREF26"
                }
            ],
            "section": "Blood-pressure regulation",
            "ref_spans": [
                {
                    "start": 157,
                    "end": 164,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Administration of angiotensin 1\u20137 into the central nervous system of rats has induced null, hypertensive, and hypotensive effects. Intracerebroventricular infusion of angiotensin 1\u20137 showed no effects in rats with normal blood pressure,113,123 and lowered blood pressure in DOCA and aldosterone salt-hypertensive rats.124,125 Conversely, injection of angiotensin 1\u20137 into the rostral ventrolateral medulla triggered an increase in blood pressure in rats with normal blood pressure and in SHRs.99,100,126",
            "cite_spans": [
                {
                    "start": 236,
                    "end": 239,
                    "mention": "113",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 240,
                    "end": 243,
                    "mention": "123",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 318,
                    "end": 321,
                    "mention": "124",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 322,
                    "end": 325,
                    "mention": "125",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 493,
                    "end": 495,
                    "mention": "99",
                    "ref_id": "BIBREF217"
                },
                {
                    "start": 496,
                    "end": 499,
                    "mention": "100",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 500,
                    "end": 503,
                    "mention": "126",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Blood-pressure regulation",
            "ref_spans": []
        },
        {
            "text": "In anaesthetized mice, acute treatment with (D-Ala7)-angiotensin-(1\u20137) showed no effect on basal or angiotensin-II-induced systolic hypertension.110 Acute central administration of (D-Ala7)-angiotensin-(1\u20137) does not change mean arterial blood pressure127 and chronic treatment does not modify the blood pressure128 in rats with normal blood pressure or SHRs. (D-Ala7)-angiotensin-(1\u20137) given centrally or systemically, however, antagonizes the hypotensive actions of ACE2 in transgenic mice108 and worsens hypertension, baroreflex dysfunction, or both in various models.120,125,129 Acute infusion of a monoclonal antibody to angiotensin 1\u20137 in SHRs notably raised blood pressure.130",
            "cite_spans": [
                {
                    "start": 50,
                    "end": 51,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 145,
                    "end": 148,
                    "mention": "110",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 187,
                    "end": 188,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 252,
                    "end": 255,
                    "mention": "127",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 312,
                    "end": 315,
                    "mention": "128",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 366,
                    "end": 367,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 491,
                    "end": 494,
                    "mention": "108",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 571,
                    "end": 574,
                    "mention": "120",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 575,
                    "end": 578,
                    "mention": "125",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 579,
                    "end": 582,
                    "mention": "129",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 680,
                    "end": 683,
                    "mention": "130",
                    "ref_id": "BIBREF35"
                }
            ],
            "section": "Blood-pressure regulation",
            "ref_spans": []
        },
        {
            "text": "In humans, infusion of angiotensin 1\u20137 induced notable vasodilator effects in control individuals with normal blood pressure and in patients with hypertension.131 Yet, in another study, acute infusion of angiotensin 1\u20137 did not change the blood pressure in individuals with normal blood pressure.132",
            "cite_spans": [
                {
                    "start": 159,
                    "end": 162,
                    "mention": "131",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 296,
                    "end": 299,
                    "mention": "132",
                    "ref_id": "BIBREF37"
                }
            ],
            "section": "Blood-pressure regulation",
            "ref_spans": []
        },
        {
            "text": "Taken together, these results suggest that ACE2 has potential blood-pressure-lowering effects via multiple mechanisms, among which catabolism of angiotensin II is likely to be essential (Figure 3). By contrast, the functional importance of ACE2-dependent angiotensin 1\u20137 production remains to be confirmed.",
            "cite_spans": [],
            "section": "Blood-pressure regulation",
            "ref_spans": [
                {
                    "start": 187,
                    "end": 195,
                    "mention": "Figure 3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "ACE2 is expressed in atherosclerotic lesions in animal and human vessels.133,134,135 The role of ACE2 in atherogenesis (Figure 4) has been investigated with use of various in vivo models.136 Systemic overexpression of ACE2 suppressed atherogenesis in apolipoprotein-E-knockout mice.137 A similar antiatherosclerotic effect of ACE2 was seen in rabbits fed with a high-cholesterol diet.138 ACE2 overexpression also stabilized the atherosclerotic plaques via inhibition of inflammation and production of matrix metalloproteinases; this effect was reversed by (D-Ala7)-angiotensin-(1\u20137).139 Conversely, loss-of-function mutations in Ace2 promoted plaque accumulation with increased expression of inflammatory adhesion molecules and cytokines.140,141,142",
            "cite_spans": [
                {
                    "start": 73,
                    "end": 76,
                    "mention": "133",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 77,
                    "end": 80,
                    "mention": "134",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 81,
                    "end": 84,
                    "mention": "135",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 187,
                    "end": 190,
                    "mention": "136",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 282,
                    "end": 285,
                    "mention": "137",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 384,
                    "end": 387,
                    "mention": "138",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 562,
                    "end": 563,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 583,
                    "end": 586,
                    "mention": "139",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 738,
                    "end": 741,
                    "mention": "140",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 742,
                    "end": 745,
                    "mention": "141",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 746,
                    "end": 749,
                    "mention": "142",
                    "ref_id": "BIBREF48"
                }
            ],
            "section": "Atherosclerosis",
            "ref_spans": [
                {
                    "start": 120,
                    "end": 128,
                    "mention": "Figure 4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "Similar to ACE2, angiotensin 1\u20137 has beneficial effects in experimental atherosclerosis (Figure 4). Long-term treatment with angiotensin 1\u20137 in apolipoprotein-E-knockout mice prevented progression of atherosclerotic lesions and improved endothelial function of nitric oxide.143 These effects seemed to involve both Mas and the AT2 receptor. Systemic administration of angiotensin 1\u20137 inhibited atherosclerotic lesion formation and enhanced plaque stability in mice in a dose-dependent manner. These effects were associated with decreased proliferation and migration of vascular smooth muscle cells, and decreased macrophage release of inflammatory cytokines.144 Activation of the angiotensin 1\u20137 receptor with AVE 0991 also inhibited atherogenesis in apolipoprotein-E-knockout mice.145,146 The atheroprotective actions of angiotensin 1\u20137 could be related to its inhibitory effects on vascular inflammation and smooth-muscle-cell proliferation and migration, probably via Mas-mediated suppression of the nuclear factor \u03baB or MAPK pathways, or both.58,144,147 Although (D-Ala7)-angiotensin-(1\u20137) alone does not modulate early atherogenesis, it seems to aggravate destabilization of atherosclerotic plaques.143,144",
            "cite_spans": [
                {
                    "start": 274,
                    "end": 277,
                    "mention": "143",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 658,
                    "end": 661,
                    "mention": "144",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 782,
                    "end": 785,
                    "mention": "145",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 786,
                    "end": 789,
                    "mention": "146",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 1047,
                    "end": 1049,
                    "mention": "58",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 1050,
                    "end": 1053,
                    "mention": "144",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 1054,
                    "end": 1057,
                    "mention": "147",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 1073,
                    "end": 1074,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 1204,
                    "end": 1207,
                    "mention": "143",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 1208,
                    "end": 1211,
                    "mention": "144",
                    "ref_id": "BIBREF50"
                }
            ],
            "section": "Atherosclerosis",
            "ref_spans": [
                {
                    "start": 89,
                    "end": 97,
                    "mention": "Figure 4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "ACE2 was originally cloned as a heart-failure-associated gene from the heart tissue of a patient with idiopathic dilated cardiomyopathy,8 but studies have not unequivocally confirmed that cardiac expression is changed in human heart failure.148,149,150,151 The level and activity of soluble ACE2 in plasma seem to be increased in patients with heart failure.23,24,152 Associations between ACE2 polymorphisms and hypertrophic cardiomyopathy have also been reported.153,154",
            "cite_spans": [
                {
                    "start": 136,
                    "end": 137,
                    "mention": "8",
                    "ref_id": "BIBREF196"
                },
                {
                    "start": 241,
                    "end": 244,
                    "mention": "148",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 245,
                    "end": 248,
                    "mention": "149",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 249,
                    "end": 252,
                    "mention": "150",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 253,
                    "end": 256,
                    "mention": "151",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 358,
                    "end": 360,
                    "mention": "23",
                    "ref_id": "BIBREF134"
                },
                {
                    "start": 361,
                    "end": 363,
                    "mention": "24",
                    "ref_id": "BIBREF135"
                },
                {
                    "start": 364,
                    "end": 367,
                    "mention": "152",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 464,
                    "end": 467,
                    "mention": "153",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 468,
                    "end": 471,
                    "mention": "154",
                    "ref_id": "BIBREF61"
                }
            ],
            "section": "Cardiac remodelling and heart failure",
            "ref_spans": []
        },
        {
            "text": "ACE2 shows multiple beneficial effects in left ventricular remodelling and dysfunction in rat models of cardiac hypertrophy induced by angiotensin II, diabetic cardiomyopathy induced by streptozotocin, and myocardial infarction induced by coronary artery occlusion.155,156,157 In mice with right ventricular dysfunction induced by pressure overload, treatment with recombinant human ACE2 reduces ventricular hypertrophy and improves systolic and diastolic functions.158 By contrast, Ace2 knockout augments angiotensin-II-induced myocardial hypertrophy and interstitial fibrosis and accelerates the transition from hypertrophy to heart failure.159,160,161,162\nAce2 knockout also aggravates cardiac dysfunction induced by diabetes in mice.163 Although the cardioprotective mechanisms of ACE2 are not completely clear, mediation of angiotensin II catabolism and subsequent inhibition of angiotensin-II-induced oxidative stress, inflammation, and interstitial fibrosis are thought to have important roles (Figure 5).156,160,163 In addition, reductions in sympathetic nerve activity might be attributable to ACE2-induced cardioprotection, as demonstrated in studies with central ACE2 overexpression (Figure 5).164",
            "cite_spans": [
                {
                    "start": 265,
                    "end": 268,
                    "mention": "155",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 269,
                    "end": 272,
                    "mention": "156",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 273,
                    "end": 276,
                    "mention": "157",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 466,
                    "end": 469,
                    "mention": "158",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 643,
                    "end": 646,
                    "mention": "159",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 647,
                    "end": 650,
                    "mention": "160",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 651,
                    "end": 654,
                    "mention": "161",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 655,
                    "end": 658,
                    "mention": "162",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 737,
                    "end": 740,
                    "mention": "163",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 1012,
                    "end": 1015,
                    "mention": "156",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 1016,
                    "end": 1019,
                    "mention": "160",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 1020,
                    "end": 1023,
                    "mention": "163",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 1205,
                    "end": 1208,
                    "mention": "164",
                    "ref_id": "BIBREF72"
                }
            ],
            "section": "Cardiac remodelling and heart failure",
            "ref_spans": [
                {
                    "start": 1002,
                    "end": 1010,
                    "mention": "Figure 5",
                    "ref_id": "FIGREF4"
                },
                {
                    "start": 1195,
                    "end": 1203,
                    "mention": "Figure 5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "Production of angiotensin 1\u20137 is substantially increased in heart failure induced by myocardial infarction.165 To date, most studies support that angiotensin 1\u20137 has protective effects on pathological cardiac remodelling and heart failure (Figure 5). For instance, systemic infusion of angiotensin 1\u20137 prevents the development of heart failure following myocardial infarction in rats.166 The angiotensin 1\u20137 receptor agonist AVE 0991 shows similar beneficial effects.167 Infusion of angiotensin 1\u20137 also prevents cardiac remodelling induced by angiotensin II in rats,168 and diabetes-induced diastolic dysfunction (with a preserved ejection fraction) in db/db mice.169 Testis-specific angiotensin 1\u20137 in transgenic rats, which doubles the concentration of circulating angiotensin 1\u20137, has notable protective effects on myocardial hypertrophy and fibrosis induced by \u03b2-adrenoceptor agonists.170,171 Treatment with angiotensin 1\u20137 also produces equivalent protective actions on pressure-overload-induced cardiac hypertrophy and remodelling as AT1-receptor blockade in ACE2-null mice.172",
            "cite_spans": [
                {
                    "start": 107,
                    "end": 110,
                    "mention": "165",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 384,
                    "end": 387,
                    "mention": "166",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 467,
                    "end": 470,
                    "mention": "167",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 567,
                    "end": 570,
                    "mention": "168",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 665,
                    "end": 668,
                    "mention": "169",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 890,
                    "end": 893,
                    "mention": "170",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 894,
                    "end": 897,
                    "mention": "171",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 1081,
                    "end": 1084,
                    "mention": "172",
                    "ref_id": "BIBREF81"
                }
            ],
            "section": "Cardiac remodelling and heart failure",
            "ref_spans": [
                {
                    "start": 240,
                    "end": 248,
                    "mention": "Figure 5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "The cardiac protective actions of angiotensin 1\u20137 are unlikely to be primarily mediated by a local mechanism in the myocardium, since the effects of cardiomyocyte-restricted overexpression on pathological cardiac remodelling seem to be inconsistent.173,174,175 Additionally, the effects of angiotensin 1\u20137 on arrhythmia are biphasic; the beneficial effects on the myocardium associated with low concentrations arise through induction of hyperpolarization and increased the conduction velocity and refractoriness, whereas high concentrations have arrhythmogenic actions.50 Whether angiotensin 1\u20137 leads to cardiac dysfunction and remodelling in rodent models of renal disease is controversial.122,176",
            "cite_spans": [
                {
                    "start": 249,
                    "end": 252,
                    "mention": "173",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 253,
                    "end": 256,
                    "mention": "174",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 257,
                    "end": 260,
                    "mention": "175",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 569,
                    "end": 571,
                    "mention": "50",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 692,
                    "end": 695,
                    "mention": "122",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 696,
                    "end": 699,
                    "mention": "176",
                    "ref_id": "BIBREF85"
                }
            ],
            "section": "Cardiac remodelling and heart failure",
            "ref_spans": []
        },
        {
            "text": "Involvement of angiotensin 1\u20137 in modulation of cerebral vascular functions and the process of ischaemic stroke (Figure 4) is supported by several studies. In ex vivo preparations of canine middle cerebral arteries, Feterik  et al.177 demonstrated that angiotensin 1\u20137 induced endothelium-dependent relaxation sensitive to blockade of nitric oxide synthase and soluble guanylyl cyclase. Relaxation induced by angiotensin 1\u20137 is not affected by (D-Ala7)-angiotensin-(1\u20137) or the AT2 receptor antagonist PD123319, but is partially blocked by a bradykinin B2 receptor antagonist.177 Similar vasodilatory effects have been observed in rat middle cerebral arteries.178 Moreover, chronic intravenous infusion of angiotensin 1\u20137 reversed endothelial dysfunction in the middle cerebral artery in rats maintained on a high-salt diet.178",
            "cite_spans": [
                {
                    "start": 231,
                    "end": 234,
                    "mention": "177",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 450,
                    "end": 451,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 576,
                    "end": 579,
                    "mention": "177",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 660,
                    "end": 663,
                    "mention": "178",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 824,
                    "end": 827,
                    "mention": "178",
                    "ref_id": "BIBREF87"
                }
            ],
            "section": "Cerebral vessels and ischaemic stroke",
            "ref_spans": [
                {
                    "start": 113,
                    "end": 121,
                    "mention": "Figure 4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "In rats with acute ischaemic stroke, expression of ACE2 and Mas are upregulated, and concentrations of local and circulating angiotensin 1\u20137 are substantially increased.179 In a rat model of stroke, induced by occlusion of middle cerebral arteries, pretreatment with angiotensin 1\u20137 by intracerebroventricular infusion was associated with reductions in infarct size and severity of neurological deficits; these effects were blocked by administration of (D-Ala7)-angiotensin-(1\u20137).180,181 The neural protective actions of angiotensin 1\u20137 in brain ischaemia, however, are unlikely to be related to alterations in cerebral blood flow. Rather, they seem to be mediated by an anti-inflammatory effect of angiotensin 1\u20137, as evidenced by reductions in the expression of inducible nitric oxide synthase and cyclo-oxygenase-2, activation of nuclear factor \u03baB, oxidative stress, and release of proinflammatory cytokines in the injured brain tissue.180,181,182",
            "cite_spans": [
                {
                    "start": 169,
                    "end": 172,
                    "mention": "179",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 459,
                    "end": 460,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 480,
                    "end": 483,
                    "mention": "180",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 484,
                    "end": 487,
                    "mention": "181",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 939,
                    "end": 942,
                    "mention": "180",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 943,
                    "end": 946,
                    "mention": "181",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 947,
                    "end": 950,
                    "mention": "182",
                    "ref_id": "BIBREF92"
                }
            ],
            "section": "Cerebral vessels and ischaemic stroke",
            "ref_spans": []
        },
        {
            "text": "Accumulating evidence has suggested that the functions of ACE2 and angiotensin 1\u20137 are affected by diabetes. Additionally, however, ACE2 and angiotensin 1\u20137 substantially affect glucose metabolism, which suggests they could have potential beneficial effects in patients with diabetes (Figure 6). Circulating ACE2 activity was increased in streptozotocin-treated rats with diabetes and in nonobese mice with diabetes.183,184 Likewise, ACE2 activity in serum was increased in humans with type 1 diabetes.185 Ectopic expression of human ACE2 in the pancreas of young db/db mice was associated with significantly decreased hyperglycaemia, improved islet function, and reduced \u03b2-cell apoptosis.186 These effects were prevented by administration of (D-Ala7)-angiotensin-(1\u20137).186 Conversely, ACE2 deficiency aggravated impaired glucose tolerance and insulin sensitivity induced by diet.187 Increased circulating concentrations of angiotensin 1\u20137, as a result of chronic infusion or transgenic expression, ameliorated hyperinsulinaemia, insulin resistance, and inflammatory responses in adipose tissue in overnourished rats,45,188,189 and increased insulin sensitivity and glucose tolerance in normoglycaemic rats.47 Moreover, in a rat model of type 2 diabetes, chronic oral treatment with an angiotensin 1\u20137 formula induced a substantial hypoglycaemic effect, improved insulin sensitivity, and prevented hyperinsulinaemia.190",
            "cite_spans": [
                {
                    "start": 416,
                    "end": 419,
                    "mention": "183",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 420,
                    "end": 423,
                    "mention": "184",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 502,
                    "end": 505,
                    "mention": "185",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 689,
                    "end": 692,
                    "mention": "186",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 749,
                    "end": 750,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 770,
                    "end": 773,
                    "mention": "186",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 880,
                    "end": 883,
                    "mention": "187",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 1117,
                    "end": 1119,
                    "mention": "45",
                    "ref_id": "BIBREF158"
                },
                {
                    "start": 1120,
                    "end": 1123,
                    "mention": "188",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 1124,
                    "end": 1127,
                    "mention": "189",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 1207,
                    "end": 1209,
                    "mention": "47",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 1416,
                    "end": 1419,
                    "mention": "190",
                    "ref_id": "BIBREF101"
                }
            ],
            "section": "Diabetes",
            "ref_spans": [
                {
                    "start": 285,
                    "end": 293,
                    "mention": "Figure 6",
                    "ref_id": "FIGREF5"
                }
            ]
        },
        {
            "text": "The mechanisms underlying the beneficial actions of ACE2 and angiotensin 1\u20137 in glucose metabolism could be multifaceted. First, activation of the RAS, especially the local RAS, for instance in skeletal muscle, adipose tissue, and the pancreas, contributes notably to the development of insulin resistance and diabetes.1,191 Hence, increased degradation of angiotensin II by ACE2 might be important in glucose metabolism. Second, angiotensin 1\u20137 can activate the phosphatidylinositol-3-kinase\u2013Akt pathway45,51,52,53,54,55 and thereby facilitate insulin-induced signalling and glucose uptake. Angiotensin 1\u20137 might also antagonize dysfunction in insulin signalling induced by angiotensin II by preventing serine phosphorylation of insulin receptor substrate 1,96 probably via inhibition of activation of MAPK pathways induced by angiotensin II.58,60,192 Moreover, evidence suggests that angiotensin 1\u20137 facilitates glucose uptake by upregulation of glucose transporter type 4 expression, which is the major glucose transporter in humans.187",
            "cite_spans": [
                {
                    "start": 319,
                    "end": 320,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 321,
                    "end": 324,
                    "mention": "191",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 504,
                    "end": 506,
                    "mention": "45",
                    "ref_id": "BIBREF158"
                },
                {
                    "start": 507,
                    "end": 509,
                    "mention": "51",
                    "ref_id": "BIBREF165"
                },
                {
                    "start": 510,
                    "end": 512,
                    "mention": "52",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 513,
                    "end": 515,
                    "mention": "53",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 516,
                    "end": 518,
                    "mention": "54",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 519,
                    "end": 521,
                    "mention": "55",
                    "ref_id": "BIBREF169"
                },
                {
                    "start": 759,
                    "end": 761,
                    "mention": "96",
                    "ref_id": "BIBREF214"
                },
                {
                    "start": 843,
                    "end": 845,
                    "mention": "58",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 846,
                    "end": 848,
                    "mention": "60",
                    "ref_id": "BIBREF175"
                },
                {
                    "start": 849,
                    "end": 852,
                    "mention": "192",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 1036,
                    "end": 1039,
                    "mention": "187",
                    "ref_id": "BIBREF97"
                }
            ],
            "section": "Diabetes",
            "ref_spans": []
        },
        {
            "text": "ACE2 and angiotensin 1\u20137 have shown remarkable protective actions against diabetic nephropathy in several studies. Clinical and experimental studies have revealed reduced ACE2 expression in the kidney in the setting of diabetes and associated kidney disease.183,193,194,195 ACE2 inhibition with MLN-4760 worsened glomerular injury in mice with streptozotocin-induced diabetes,29 and Ace2 knockout accelerated diabetes-induced kidney injuries.196,197 Increasing the ACE2 function in Akita mice with diabetes by systemic treatment with recombinant ACE2, however, ameliorated albuminuria and prevents glomerular proliferation, fibrosis, and oxidative stress.198 In rats with diabetes, global overexpression of ACE2 has produced remarkable renal protection similar to that induced by the ACE inhibitor benazepril, but no synergistic actions between ACE inhibition and ACE2 have been observed.199 Local overexpression of ACE2 in renal podocytes also seems to prevent kidney injuries in mice with diabetes.200 Additionally, chronic systemic treatment with angiotensin 1\u20137 reduced the risk of renal fibrosis, oxidative stress, and inflammation in the Zucker obese rat model of type 2 diabetes.201",
            "cite_spans": [
                {
                    "start": 258,
                    "end": 261,
                    "mention": "183",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 262,
                    "end": 265,
                    "mention": "193",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 266,
                    "end": 269,
                    "mention": "194",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 270,
                    "end": 273,
                    "mention": "195",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 376,
                    "end": 378,
                    "mention": "29",
                    "ref_id": "BIBREF140"
                },
                {
                    "start": 442,
                    "end": 445,
                    "mention": "196",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 446,
                    "end": 449,
                    "mention": "197",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 655,
                    "end": 658,
                    "mention": "198",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 888,
                    "end": 891,
                    "mention": "199",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 1000,
                    "end": 1003,
                    "mention": "200",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 1186,
                    "end": 1189,
                    "mention": "201",
                    "ref_id": "BIBREF114"
                }
            ],
            "section": "Diabetes",
            "ref_spans": []
        },
        {
            "text": "ACE2 is highly expressed in gut tissues, at least in rodents.202 ACE2 in the gut has been shown to have a critical role in the regulation of intestinal innate immunity, amino acid homeostasis, and the ecology of the gut microbiota.203 ACE2 deficiency results in increased susceptibility to intestinal inflammation induced by epithelial damage.203 Of note, some evidence suggests that metabolism of dietary components by the intestinal microbiota might also have effects on the cardiovascular health,204 which raises the possibility that ACE2 expressed in the gut contributes to vascular protection indirectly by modulating the interactions between gut microbiota and the intestinal epithelium.",
            "cite_spans": [
                {
                    "start": 61,
                    "end": 64,
                    "mention": "202",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 231,
                    "end": 234,
                    "mention": "203",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 343,
                    "end": 346,
                    "mention": "203",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 499,
                    "end": 502,
                    "mention": "204",
                    "ref_id": "BIBREF117"
                }
            ],
            "section": "The gut",
            "ref_spans": []
        },
        {
            "text": "The success of chemical ACE inhibitors and AT1-receptor blockers in clinical management of various cardiovascular diseases underscores the possibility that searching for chemical modulators that target other active components of RAS could be fruitful. In a first-in-human study, human recombinant ACE2 was administered intravenously to healthy volunteers to assess the pharmacokinetic, pharmacodynamic, and safety profiles of native ACE2.205 Bioavailability of recombinant ACE2 in the human body showed a linear dose-dependent increase and had a terminal elimination half-life of \u223c10 h. Strikingly, within 30 min of administration of ACE2 at 400 \u03bcg/kg and 1,200 \u03bcg/kg, the plasma concentration of angiotensin II dropped and remained suppressed for more than 24 h. The level of angiotensin 1\u20137 varied in response to different doses of ACE2. Recombinant ACE2 was well tolerated, with no obvious effects on haemodynamic parameters.205 These results also highlight the possibility that, in humans, the potential cardiovascular protective actions of raised ACE2 concentrations might largely be mediated by the accelerated catabolism of angiotensin II.",
            "cite_spans": [
                {
                    "start": 438,
                    "end": 441,
                    "mention": "205",
                    "ref_id": "BIBREF118"
                },
                {
                    "start": 928,
                    "end": 931,
                    "mention": "205",
                    "ref_id": "BIBREF118"
                }
            ],
            "section": "Targeted clinical therapies",
            "ref_spans": []
        },
        {
            "text": "The basic pharmacokinetic and safety profiles of native angiotensin 1\u20137 were mainly obtained from several studies in patients with cancer.40,206 Native angiotensin 1\u20137 causes vasodilatation in healthy individuals and patients with hypertension,131 but it shows no effect in patients with heart failure.207 Angiotensin 1\u20137 is continuously catabolized by ACE, NEP, and aminopeptidases; therefore, decreased degradation seems to be a plausible contributor to the beneficial effects of ACE inhibitors.42 The value of angiotensin 1\u20137 as a therapeutic agent could be limited by the very short half-life of this peptide in the body. An ACE-resistant, cyclic angiotensin 1\u20137 analogue, in which a thioether bridge is introduced to the modified residues 4 and 7 of angiotensin 1\u20137, has been described.208 The bridged peptide was highly resistant to ACE activity, and showed a substantial (34-fold) reduction in plasma clearance in rats. Moreover, this agent induced a Mas-dependent vasodilator effect in isolated rat aorta.208 Thioether-bridged angiotensin 1\u20137 is stable at low (2.0) pH and is bioavailable after oral administration in rats.209 In a rat model of myocardial infarction, chronic infusion of thioether-bridged angiotensin 1\u20137 started 2 weeks after the infarction suppressed myocyte hypertrophy and improved cardiac and vascular functions.210",
            "cite_spans": [
                {
                    "start": 138,
                    "end": 140,
                    "mention": "40",
                    "ref_id": "BIBREF153"
                },
                {
                    "start": 141,
                    "end": 144,
                    "mention": "206",
                    "ref_id": "BIBREF119"
                },
                {
                    "start": 244,
                    "end": 247,
                    "mention": "131",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 302,
                    "end": 305,
                    "mention": "207",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 497,
                    "end": 499,
                    "mention": "42",
                    "ref_id": "BIBREF155"
                },
                {
                    "start": 791,
                    "end": 794,
                    "mention": "208",
                    "ref_id": "BIBREF121"
                },
                {
                    "start": 1013,
                    "end": 1016,
                    "mention": "208",
                    "ref_id": "BIBREF121"
                },
                {
                    "start": 1131,
                    "end": 1134,
                    "mention": "209",
                    "ref_id": "BIBREF122"
                },
                {
                    "start": 1342,
                    "end": 1345,
                    "mention": "210",
                    "ref_id": "BIBREF124"
                }
            ],
            "section": "Targeted clinical therapies",
            "ref_spans": []
        },
        {
            "text": "A hydroxypropyl \u03b2-cyclodextrin-incorporated angiotensin 1\u20137 formulation (HP\u03b2CD/Ang1\u20137) designed to overcome the instability of native angiotensin 1\u20137 in the gastrointestinal tract has been created.211 Oral treatment with HP\u03b2CD/Ang1\u20137 has shown remarkable cardioprotective effects in rats with myocardial infarction and pathological remodelling after coronary artery occlusion.211,212 Moreover, orally administered HP\u03b2CD/Ang1\u20137 was associated with improved lipid metabolism and prevention of hepatic steatosis in mice fed a high-fat diet.213 Similarly, long-term oral HP\u03b2CD/Ang1\u20137 treatment was found to reverse established hyperglycaemia, improve insulin sensitivity, and prevent diabetic nephropathy in a transgenic rat model of insulin resistance and type 2 diabetes.190",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 200,
                    "mention": "211",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 376,
                    "end": 379,
                    "mention": "211",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 380,
                    "end": 383,
                    "mention": "212",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 537,
                    "end": 540,
                    "mention": "213",
                    "ref_id": "BIBREF127"
                },
                {
                    "start": 769,
                    "end": 772,
                    "mention": "190",
                    "ref_id": "BIBREF101"
                }
            ],
            "section": "Targeted clinical therapies",
            "ref_spans": []
        },
        {
            "text": "Our understanding of the roles of ACE2 and angiotensin 1\u20137 is mainly derived from studies of experimental models.7,214,215,216,217 and evidence for biological actions in humans is sparse. Nevertheless, new drugs or pharmaceutical formulations targeting ACE2 and angiotensin 1\u20137 are expected to have strong clinical potential to treat cardiovascular diseases, especially those associated with increased activation of the conventional RAS. Research taking various directions,218 including modifications of native ACE2 and angiotensin 1\u20137 and identification of compounds that can specifically modulate the functions of ACE2, is underway. The latter might include small-molecule ACE2 activators and angiotensin 1\u20137 mimetics. Clearly, randomized, controlled clinical trials are required to assess the therapeutic efficacy and safety of targeted interventions.",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 114,
                    "mention": "7",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 115,
                    "end": 118,
                    "mention": "214",
                    "ref_id": "BIBREF128"
                },
                {
                    "start": 119,
                    "end": 122,
                    "mention": "215",
                    "ref_id": "BIBREF129"
                },
                {
                    "start": 123,
                    "end": 126,
                    "mention": "216",
                    "ref_id": "BIBREF130"
                },
                {
                    "start": 127,
                    "end": 130,
                    "mention": "217",
                    "ref_id": "BIBREF131"
                },
                {
                    "start": 473,
                    "end": 476,
                    "mention": "218",
                    "ref_id": "BIBREF132"
                }
            ],
            "section": "Targeted clinical therapies",
            "ref_spans": []
        },
        {
            "text": "Numerous experimental studies have suggested that ACE2 has protective effects in the heart and blood vessels, primarily by modulating the homeostasis of systemic neurohumoral factors and by improving cardiovascular risk factors. ACE2-mediated catabolism of angiotensin II is likely to have a major role in cardiovascular protection, especially in patients with overactive RAS. Interventions targeting ACE2, therefore, might represent a promising direction in the discovery of novel therapies for cardiovascular disease.",
            "cite_spans": [],
            "section": "Conclusions",
            "ref_spans": []
        },
        {
            "text": "By contrast, the physiological and pharmacological actions of angiotensin 1\u20137 are complex and even paradoxical in certain circumstances, such as in the kidney. Similarly, the effects of angiotensin 1\u20137 on blood-pressure regulation are variable. Infusion of angiotensin 1\u20137 induces either vasodilatation or a null effect in normotensive humans. The effects of angiotensin 1\u20137 on cardiac dysfunction and remodelling caused by renal disease in rodents are contradictory in different studies. Moreover, angiotensin 1\u20137 shows biphasic actions on cardiac arrhythmia following myocardial injury. Therefore, more studies, especially controlled clinical trials, are needed to clearly delineate the benefits of angiotensin-1\u20137-based therapies.",
            "cite_spans": [],
            "section": "Conclusions",
            "ref_spans": []
        },
        {
            "text": "The articles reviewed in this paper were selected from the PubMed database using the search terms: \u201cangiotensin-converting enzyme 2 OR ACE2\u201d, or \u201cangiotensin 1-7\u201d or \u201cMas\u201d, plus other identifiers, including (but not limited to) \u201chypertension OR blood pressure\u201d, \u201catherosclerosis\u201d, \u201cheart OR cardiac remodeling\u201d, \u201cdiabetes OR insulin resistance OR hyperinsulinaemia\u201d, and \u201cstroke OR cerebral vascular\u201d. Review articles were filtered by using the search term \u201creview [pt]\u201d. Articles relating to the biochemistry and pharmacology of ACE2/angiotensin 1-7/Mas were searched using terms including \u201cbiochemistry\u201d, \u201cinhibitor OR antagonist\u201d, \u201cagonist OR activator\u201d, \u201cbinding affinity\u201d, \u201cligand binding\u201d, or \u201cpharmacokinetics OR pharmacodynamics\u201d. On some occasions, terms including \u201cdomain structure\u201d, \u201cdomains\u201d, or \u201ccrystallography\u201d were also used for a general search in the internet. We applied no restrictions on date of publication or origin of the work, but only articles published in English were included. Most of the papers cited were full-text articles. Selected reference lists from retrieved papers were used to identify further relevant citations. During the revision stage we searched again to update the reference list with the latest published articles.",
            "cite_spans": [],
            "section": "Review criteria",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: \nPowerPoint slide\n\n*Effects observed only in the presence of bradykinin. \u2021Some beneficial effects observed in exercise-trained animals and for endogenous Ang 1\u20137. Abbreviations: 2K1C, two-kidney one clip; ACE2, angiotensin-converting enzyme 2; Ang, angiotensin; BP, blood pressure; CNS, central nervous system; DOCA, deoxycorticosterone-acetate; RHR, renal hypertensive rat; SHR, spontaneously hypertensive rat.",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: ACE2 converts Ang II to Ang 1\u20137. ACE2 can also convert Ang I to Ang 1\u20139, which is then cleaved by either NEP or ACE to yield Ang 1-7. The membrane-bound ACE2 can be cleaved by the metalloproteinase ADAM17, forming a soluble form of ACE2. The physiological relevance of soluble ACE2 is not fully understood. Abbreviations: ACE, angiotensin-converting enzyme; Ang, angiotensin; NEP, neutral endopeptidase; PCP, prolyl carboxypeptidase. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: In this image, the extracellular domain is arbitrarily divided into two subdomains (shown in green and purple), forming a deep cleft that is proposed to be the active site for substrate binding and catalysis. The catalytic domain (amino acids 147\u2013555) has a substrate binding region (amino acids 273\u2013345) and a typical HEMGH metalloproteinase zinc-binding site (amino acids 374\u2013378). The regions shown in ball-and-stick figuration are proposed binding sites for the ACE2 inhibitor MLN-4760. Abbreviation: ACE2, angiotensin-converting enzyme 2. Amino acid sequence annotations are derived from Towler, P.  et al. J. Biol. Chem.\n279, 17996\u201318007 (2004).28 \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: ACE2 is known to cause reductions in blood pressure, whereas various experimental evidence has indicated no effects, hypotensive effects, and hypertensive effects of Ang 1\u20137. Abbreviations: ACE2, angiotensin-converting enzyme 2; Ang, angiotensin; CNS, central nervous system; PVN, paraventricular nucleus, RVLM, rostral ventrolateral medulla. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: Abbreviations: ACE2, angiotensin-converting enzyme 2; Ang, angiotensin; VSMC, vascular smooth muscle cell. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Figure 5: Abbreviations: ACE2, angiotensin-converting enzyme 2; Ang, angiotensin. \nPowerPoint slide\n",
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Figure 6: The conversion of Ang II to Ang 1-7 by ACE2 is increased in type 1 and in type 2 diabetes. Ang 1-7 increases insulin sensitivity and glucose uptake through activation of PI3K\u2013Akt signalling and reduction of pancreatic \u03b2-cell apoptosis. Blockade of the effects of ACE2 by MLN-4760, or Ang 1-7 by A-779, might reverse the metabolic effects of ACE2 and Ang 1-7 and thereby worsen vascular complications. Abbreviations: ACE, angiotensin-converting enzyme; Ang, angiotensin; PI3K, phosphatidylinositol 3-kinase. \nPowerPoint slide\n",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Putnam",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Shoemaker",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Yiannikouris",
                    "suffix": ""
                },
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Cassis",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "302",
            "issn": "",
            "pages": "H1219-H1230",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Three key proteases\u2014angiotensin-I-converting enzyme (ACE), ACE2 and renin\u2014within and beyond the renin-angiotensin system",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guang",
                    "suffix": ""
                },
                {
                    "first": "RD",
                    "middle": [],
                    "last": "Phillips",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Milani",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Arch. Cardiovasc. Dis.",
            "volume": "105",
            "issn": "",
            "pages": "373-385",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Characterization of a new selective antagonist for angiotensin-(1\u20137), D-pro7-angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Hypertension",
            "volume": "41",
            "issn": "",
            "pages": "737-743",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1\u20137) on the endothelium",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wiemer",
                    "suffix": ""
                },
                {
                    "first": "LW",
                    "middle": [],
                    "last": "Dobrucki",
                    "suffix": ""
                },
                {
                    "first": "FR",
                    "middle": [],
                    "last": "Louka",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Malinski",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Heitsch",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Hypertension",
            "volume": "40",
            "issn": "",
            "pages": "847-852",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Nonpeptide AVE 0991 is an angiotensin-(1\u20137) receptor Mas agonist in the mouse kidney",
            "authors": [
                {
                    "first": "SV",
                    "middle": [],
                    "last": "Pinheiro",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Hypertension",
            "volume": "44",
            "issn": "",
            "pages": "490-496",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor",
            "authors": [
                {
                    "first": "SQ",
                    "middle": [],
                    "last": "Savergnini",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Hypertension",
            "volume": "56",
            "issn": "",
            "pages": "112-120",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice",
            "authors": [
                {
                    "first": "SB",
                    "middle": [],
                    "last": "Gurley",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J. Clin. Invest.",
            "volume": "116",
            "issn": "",
            "pages": "2218-2225",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yamazato",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yamazato",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Diez-Freire",
                    "suffix": ""
                },
                {
                    "first": "MK",
                    "middle": [],
                    "last": "Raizada",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Hypertension",
            "volume": "49",
            "issn": "",
            "pages": "926-931",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sriramula",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Cardinale",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lazartigues",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Francis",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Cardiovasc. Res.",
            "volume": "92",
            "issn": "",
            "pages": "401-408",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Circ. Res.",
            "volume": "102",
            "issn": "",
            "pages": "729-736",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Circ. Res.",
            "volume": "106",
            "issn": "",
            "pages": "373-382",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rentzsch",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Hypertension",
            "volume": "52",
            "issn": "",
            "pages": "967-973",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuba",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Imai",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Penninger",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Circ. J.",
            "volume": "77",
            "issn": "",
            "pages": "301-308",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wysocki",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Hypertension",
            "volume": "55",
            "issn": "",
            "pages": "90-98",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lo",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Exp. Physiol.",
            "volume": "98",
            "issn": "",
            "pages": "109-122",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1\u20137) in normotensive and hypertensive rats",
            "authors": [
                {
                    "first": "CV",
                    "middle": [],
                    "last": "Lima",
                    "suffix": ""
                },
                {
                    "first": "RD",
                    "middle": [],
                    "last": "Paula",
                    "suffix": ""
                },
                {
                    "first": "FL",
                    "middle": [],
                    "last": "Resende",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Khosla",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Hypertension",
            "volume": "30",
            "issn": "",
            "pages": "542-548",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Differential baroreceptor reflex modulation by centrally infused angiotensin peptides",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Campagnole-Santos",
                    "suffix": ""
                },
                {
                    "first": "SB",
                    "middle": [],
                    "last": "Heringer",
                    "suffix": ""
                },
                {
                    "first": "EN",
                    "middle": [],
                    "last": "Batista",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Khosla",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Am. J. Physiol.",
            "volume": "263",
            "issn": "",
            "pages": "R89-R94",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Systemic and regional hemodynamic effects of angiotensin-(1\u20137) in rats",
            "authors": [
                {
                    "first": "WO",
                    "middle": [],
                    "last": "Sampaio",
                    "suffix": ""
                },
                {
                    "first": "AA",
                    "middle": [],
                    "last": "Nascimento",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "284",
            "issn": "",
            "pages": "H1985-H1994",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "1A-779 attenuates angiotensin-(1\u20137) depressor response in salt-induced hypertensive rats",
            "authors": [
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Bayorh",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Peptides",
            "volume": "23",
            "issn": "",
            "pages": "57-64",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Angiotensin-(1\u20137) induces bradykinin-mediated hypotensive responses in anesthetized rats",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abbas",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Gorelik",
                    "suffix": ""
                },
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Carbini",
                    "suffix": ""
                },
                {
                    "first": "AG",
                    "middle": [],
                    "last": "Scicli",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Hypertension",
            "volume": "30",
            "issn": "",
            "pages": "217-221",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Antihypertensive actions of angiotensin-(1\u20137) in spontaneously hypertensive rats",
            "authors": [
                {
                    "first": "IF",
                    "middle": [],
                    "last": "Benter",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                },
                {
                    "first": "DI",
                    "middle": [],
                    "last": "Diz",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Am. J. Physiol.",
            "volume": "269",
            "issn": "",
            "pages": "H313-H319",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Gender differences in the attenuation of salt-induced hypertension by angiotensin (1\u20137)",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Eatman",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Peptides",
            "volume": "22",
            "issn": "",
            "pages": "927-933",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Chronic angiotensin-(1\u20137) prevents cardiac fibrosis in DOCA-salt model of hypertension",
            "authors": [
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Grobe",
                    "suffix": ""
                },
                {
                    "first": "AP",
                    "middle": [],
                    "last": "Mecca",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Katovich",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "290",
            "issn": "",
            "pages": "H2417-H2423",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Angiotensin-converting enzyme 2: the first decade",
            "authors": [
                {
                    "first": "NE",
                    "middle": [],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Turner",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Int. J. Hypertens.",
            "volume": "2012",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Impairment of the angiotensin-converting enzyme 2-angiotensin-(1\u20137)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Burgelova",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J. Hypertens.",
            "volume": "27",
            "issn": "",
            "pages": "1988-2000",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Angiotensin-(1\u20137) attenuates hypertension in exercise-trained renal hypertensive rats",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shah",
                    "suffix": ""
                },
                {
                    "first": "YB",
                    "middle": [],
                    "last": "Oh",
                    "suffix": ""
                },
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "302",
            "issn": "",
            "pages": "H2372-H2380",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Angiotensin-(1\u20137) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Velkoska",
                    "suffix": ""
                },
                {
                    "first": "RG",
                    "middle": [],
                    "last": "Dean",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Griggs",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Burchill",
                    "suffix": ""
                },
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Burrell",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Clin. Sci. (Lond.)",
            "volume": "120",
            "issn": "",
            "pages": "335-345",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Moriguchi",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "KB",
                    "middle": [],
                    "last": "Brosnihan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ganten",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Am. J. Physiol.",
            "volume": "267",
            "issn": "",
            "pages": "R786-R791",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Chronic infusion of angiotensin-(1\u20137) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats",
            "authors": [
                {
                    "first": "PS",
                    "middle": [],
                    "last": "Guimaraes",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "303",
            "issn": "",
            "pages": "H393-H400",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Central endogenous angiotensin-(1\u20137) protects against aldosterone/NaCl-induced hypertension in female rats",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "305",
            "issn": "",
            "pages": "H699-H705",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Role of angiotensin-(1\u20137) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nakagaki",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Clin. Exp. Hypertens.",
            "volume": "33",
            "issn": "",
            "pages": "223-230",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats",
            "authors": [
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Oliveira",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                },
                {
                    "first": "GF",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Khosla",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Campagnole-Santos",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Hypertension",
            "volume": "27",
            "issn": "",
            "pages": "1284-1290",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Diuresis and natriuresis produced by long term administration of a selective angiotensin-(1\u20137) antagonist in normotensive and hypertensive rats",
            "authors": [
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Simoes e Silva",
                    "suffix": ""
                },
                {
                    "first": "AP",
                    "middle": [],
                    "last": "Bello",
                    "suffix": ""
                },
                {
                    "first": "NC",
                    "middle": [],
                    "last": "Baracho",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Khosla",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Regul. Pept.",
            "volume": "74",
            "issn": "",
            "pages": "177-184",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Role of angiotensin-(1\u20137) in the modulation of the baroreflex in renovascular hypertensive rats",
            "authors": [
                {
                    "first": "RR",
                    "middle": [],
                    "last": "Britto",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                },
                {
                    "first": "CR",
                    "middle": [],
                    "last": "Fagundes-Moura",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Khosla",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Campagnole-Santos",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Hypertension",
            "volume": "30",
            "issn": "",
            "pages": "549-556",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis",
            "authors": [
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Guy",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                },
                {
                    "first": "HA",
                    "middle": [],
                    "last": "Jensen",
                    "suffix": ""
                },
                {
                    "first": "NM",
                    "middle": [],
                    "last": "Hooper",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Turner",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "FEBS J.",
            "volume": "272",
            "issn": "",
            "pages": "3512-3520",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Vasodepressor actions of angiotensin-(1\u20137) unmasked during combined treatment with lisinopril and losartan",
            "authors": [
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Iyer",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Chappell",
                    "suffix": ""
                },
                {
                    "first": "DB",
                    "middle": [],
                    "last": "Averill",
                    "suffix": ""
                },
                {
                    "first": "DI",
                    "middle": [],
                    "last": "Diz",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Hypertension",
            "volume": "31",
            "issn": "",
            "pages": "699-705",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Effects of angiotensin-(1\u20137) on forearm circulation in normotensive subjects and patients with essential hypertension",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sasaki",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Hypertension",
            "volume": "38",
            "issn": "",
            "pages": "90-94",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Effects of truncated angiotensins in humans after double blockade of the renin system",
            "authors": [
                {
                    "first": "RR",
                    "middle": [],
                    "last": "Plovsing",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Am. J. Physiol. Regul. Integr. Comp. Physiol.",
            "volume": "285",
            "issn": "",
            "pages": "R981-R991",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zulli",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rai",
                    "suffix": ""
                },
                {
                    "first": "BF",
                    "middle": [],
                    "last": "Buxton",
                    "suffix": ""
                },
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Burrell",
                    "suffix": ""
                },
                {
                    "first": "DL",
                    "middle": [],
                    "last": "Hare",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Exp. Physiol.",
            "volume": "93",
            "issn": "",
            "pages": "564-569",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1\u20137 is increased in diabetic atheroma: implications for inflammation and neovascularization",
            "authors": [
                {
                    "first": "KR",
                    "middle": [],
                    "last": "Purushothaman",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Cardiovasc. Pathol.",
            "volume": "22",
            "issn": "",
            "pages": "42-48",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions",
            "authors": [
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Sluimer",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J. Pathol.",
            "volume": "215",
            "issn": "",
            "pages": "273-279",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Angiotensin converting enzyme 2 and atherosclerosis",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tikellis",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Golledge",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Atherosclerosis",
            "volume": "226",
            "issn": "",
            "pages": "3-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lovren",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "295",
            "issn": "",
            "pages": "H1377-H1384",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "107",
            "issn": "",
            "pages": "15886-15891",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arterioscler. Thromb. Vasc. Biol.",
            "volume": "28",
            "issn": "",
            "pages": "1270-1276",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J. Biol. Chem.",
            "volume": "276",
            "issn": "",
            "pages": "17132-17139",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse",
            "authors": [
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Circ. Res.",
            "volume": "107",
            "issn": "",
            "pages": "888-897",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor\u2212/\u2212 mice",
            "authors": [
                {
                    "first": "SE",
                    "middle": [],
                    "last": "Thatcher",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Arterioscler. Thromb. Vasc. Biol.",
            "volume": "31",
            "issn": "",
            "pages": "758-765",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sahara",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Cardiovasc. Res.",
            "volume": "101",
            "issn": "",
            "pages": "236-246",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "Vasoprotective and atheroprotective effects of angiotensin (1\u20137) in apolipoprotein E-deficient mice",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tesanovic",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vinh",
                    "suffix": ""
                },
                {
                    "first": "TA",
                    "middle": [],
                    "last": "Gaspari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Casley",
                    "suffix": ""
                },
                {
                    "first": "RE",
                    "middle": [],
                    "last": "Widdop",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Arterioscler. Thromb. Vasc. Biol.",
            "volume": "30",
            "issn": "",
            "pages": "1606-1613",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF50": {
            "title": "Angiotensin-(1\u20137) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Arterioscler. Thromb. Vasc. Biol.",
            "volume": "33",
            "issn": "",
            "pages": "1978-1985",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF51": {
            "title": "AVE 0991-angiotensin-(1\u20137) receptor agonist, inhibits atherogenesis in apoE-knockout mice",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Toton-Zuranska",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J. Physiol. Pharmacol.",
            "volume": "61",
            "issn": "",
            "pages": "181-183",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF52": {
            "title": "Angiotensin-(1\u20137) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jawien",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J. Physiol. Pharmacol.",
            "volume": "63",
            "issn": "",
            "pages": "77-85",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF53": {
            "title": "Angiotensin-(1\u20137) regulates angiotensin II-induced VCAM-1 expression on vascular endothelial cells",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ren",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Biochem. Biophys. Res. Commun.",
            "volume": "430",
            "issn": "",
            "pages": "642-646",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF54": {
            "title": "ACE2 gene expression is up-regulated in the human failing heart",
            "authors": [
                {
                    "first": "AB",
                    "middle": [],
                    "last": "Goulter",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Goddard",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Allen",
                    "suffix": ""
                },
                {
                    "first": "KL",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "BMC Med.",
            "volume": "2",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF55": {
            "title": "Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ohtsuki",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Int. J. Cardiol.",
            "volume": "145",
            "issn": "",
            "pages": "333-334",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence",
            "authors": [
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Guy",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Biochemistry",
            "volume": "42",
            "issn": "",
            "pages": "13185-13192",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure",
            "authors": [
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Kittleson",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Physiol. Genomics",
            "volume": "21",
            "issn": "",
            "pages": "299-307",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF58": {
            "title": "Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Batlle",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J. Heart Lung Transplant",
            "volume": "25",
            "issn": "",
            "pages": "1117-1125",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF59": {
            "title": "Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J. Card. Fail.",
            "volume": "16",
            "issn": "",
            "pages": "157-163",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF60": {
            "title": "Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lieb",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J. Mol. Med. (Berl.)",
            "volume": "84",
            "issn": "",
            "pages": "88-96",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF61": {
            "title": "Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "van der Merwe",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Hum. Genet.",
            "volume": "124",
            "issn": "",
            "pages": "57-61",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF62": {
            "title": "Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Huentelman",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Exp. Physiol.",
            "volume": "90",
            "issn": "",
            "pages": "783-790",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF63": {
            "title": "Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J. Am. Coll. Cardiol.",
            "volume": "59",
            "issn": "",
            "pages": "739-747",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF64": {
            "title": "ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction",
            "authors": [
                {
                    "first": "YX",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Hum. Gene Ther.",
            "volume": "21",
            "issn": "",
            "pages": "1545-1554",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF65": {
            "title": "ACE2 improves right ventricular function in a pressure overload model",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "West",
                    "suffix": ""
                },
                {
                    "first": "KB",
                    "middle": [],
                    "last": "Maynard",
                    "suffix": ""
                },
                {
                    "first": "AR",
                    "middle": [],
                    "last": "Hemnes",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "PLoS ONE",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF66": {
            "title": "Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice",
            "authors": [
                {
                    "first": "GY",
                    "middle": [],
                    "last": "Oudit",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Cardiovasc. Res.",
            "volume": "75",
            "issn": "",
            "pages": "29-39",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vickers",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J. Biol. Chem.",
            "volume": "277",
            "issn": "",
            "pages": "14838-14843",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF68": {
            "title": "Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Circulation",
            "volume": "122",
            "issn": "",
            "pages": "717-728",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF69": {
            "title": "Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bodiga",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Cardiovasc. Res.",
            "volume": "91",
            "issn": "",
            "pages": "151-161",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF70": {
            "title": "Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yamamoto",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hypertension",
            "volume": "47",
            "issn": "",
            "pages": "718-726",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF71": {
            "title": "Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis",
            "authors": [
                {
                    "first": "VB",
                    "middle": [],
                    "last": "Patel",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Circ. Res.",
            "volume": "110",
            "issn": "",
            "pages": "1322-1335",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF72": {
            "title": "Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hans",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "McIlwain",
                    "suffix": ""
                },
                {
                    "first": "KJ",
                    "middle": [],
                    "last": "Varner",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lazartigues",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "PLoS ONE",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF73": {
            "title": "Cardiac angiotensin-(1\u20137) in ischemic cardiomyopathy",
            "authors": [
                {
                    "first": "DB",
                    "middle": [],
                    "last": "Averill",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ishiyama",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Chappell",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Circulation",
            "volume": "108",
            "issn": "",
            "pages": "2141-2146",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF74": {
            "title": "Angiotensin-(1\u20137) attenuates the development of heart failure after myocardial infarction in rats",
            "authors": [
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Loot",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Circulation",
            "volume": "105",
            "issn": "",
            "pages": "1548-1550",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF75": {
            "title": "The nonpeptide angiotensin-(1\u20137) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction",
            "authors": [
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "292",
            "issn": "",
            "pages": "H1113-H1119",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF76": {
            "title": "Angiotensin 1\u20137 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mori",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Circ. Heart Fail.",
            "volume": "7",
            "issn": "",
            "pages": "327-339",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF77": {
            "title": "Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Grobe",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "292",
            "issn": "",
            "pages": "H736-H742",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF78": {
            "title": "Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1\u20137) in regulation of cardiovascular function",
            "authors": [
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Trask",
                    "suffix": ""
                },
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Jessup",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "289",
            "issn": "",
            "pages": "H2281-H2290",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF79": {
            "title": "Expression of an angiotensin-(1\u20137)-producing fusion protein produces cardioprotective effects in rats",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Physiol. Genomics",
            "volume": "17",
            "issn": "",
            "pages": "292-299",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF80": {
            "title": "Reduced isoproterenol-induced renin-angiotensin changes and extracellular matrix deposition in hearts of TGR(A1\u20137)3292 rats",
            "authors": [
                {
                    "first": "AP",
                    "middle": [],
                    "last": "Nadu",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                },
                {
                    "first": "TL",
                    "middle": [],
                    "last": "Reudelhuber",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bader",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J. Am. Soc. Hypertens.",
            "volume": "2",
            "issn": "",
            "pages": "341-348",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF81": {
            "title": "Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1\u20137 in experimental heart failure in angiotensin-converting enzyme 2-null mice",
            "authors": [
                {
                    "first": "VB",
                    "middle": [],
                    "last": "Patel",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Hypertension",
            "volume": "59",
            "issn": "",
            "pages": "1195-1203",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF82": {
            "title": "Circulating rather than cardiac angiotensin-(1\u20137) stimulates cardioprotection after myocardial infarction",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Circ. Heart Fail.",
            "volume": "3",
            "issn": "",
            "pages": "286-293",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF83": {
            "title": "Angiotensin(1\u20137) blunts hypertensive cardiac remodeling by a direct effect on the heart",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mercure",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Circ. Res.",
            "volume": "103",
            "issn": "",
            "pages": "1319-1326",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF84": {
            "title": "Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1\u20137)-producing fusion protein in the heart",
            "authors": [
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Ther. Adv. Cardiovasc. Dis.",
            "volume": "4",
            "issn": "",
            "pages": "83-96",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF85": {
            "title": "Angiotensin (1\u20137) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Hypertens. Res.",
            "volume": "32",
            "issn": "",
            "pages": "369-374",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF86": {
            "title": "Angiotensin-(1\u20137) causes endothelium-dependent relaxation in canine middle cerebral artery",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Feterik",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "ZS",
                    "middle": [],
                    "last": "Katusic",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Brain Res.",
            "volume": "873",
            "issn": "",
            "pages": "75-82",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF87": {
            "title": "Angiotensin-(1\u20137) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Durand",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Raffai",
                    "suffix": ""
                },
                {
                    "first": "BD",
                    "middle": [],
                    "last": "Weinberg",
                    "suffix": ""
                },
                {
                    "first": "JH",
                    "middle": [],
                    "last": "Lombard",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "299",
            "issn": "",
            "pages": "H1024-H1033",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF88": {
            "title": "The expression of angiotensin-converting enzyme 2-angiotensin-(1\u20137)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Neuropeptides",
            "volume": "47",
            "issn": "",
            "pages": "289-295",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF89": {
            "title": "Angiotensin-converting enzyme 2, angiotensin-(1\u20137) and Mas: new players of the renin-angiotensin system",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Verano-Braga",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bader",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J. Endocrinol.",
            "volume": "216",
            "issn": "",
            "pages": "R1-R17",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF90": {
            "title": "Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke",
            "authors": [
                {
                    "first": "AP",
                    "middle": [],
                    "last": "Mecca",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Exp. Physiol.",
            "volume": "96",
            "issn": "",
            "pages": "1084-1096",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF91": {
            "title": "Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1\u20137) in rats with permanent cerebral ischaemia",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Br. J. Pharmacol.",
            "volume": "167",
            "issn": "",
            "pages": "1520-1532",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF92": {
            "title": "Anti-inflammatory effects of angiotensin-(1\u20137) in ischemic stroke",
            "authors": [
                {
                    "first": "RW",
                    "middle": [],
                    "last": "Regenhardt",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Neuropharmacology",
            "volume": "71",
            "issn": "",
            "pages": "154-163",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF93": {
            "title": "Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes",
            "authors": [
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Yamaleyeva",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am. J. Physiol. Renal Physiol.",
            "volume": "302",
            "issn": "",
            "pages": "F1374-F1384",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF94": {
            "title": "Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Riera",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "PLoS ONE",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF95": {
            "title": "Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Soro-Paavonen",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J. Hypertens.",
            "volume": "30",
            "issn": "",
            "pages": "375-383",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF96": {
            "title": "Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice",
            "authors": [
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Bindom",
                    "suffix": ""
                },
                {
                    "first": "CP",
                    "middle": [],
                    "last": "Hans",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "AH",
                    "middle": [],
                    "last": "Boulares",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lazartigues",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Diabetes",
            "volume": "59",
            "issn": "",
            "pages": "2540-2548",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF97": {
            "title": "Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Takeda",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Diabetes",
            "volume": "62",
            "issn": "",
            "pages": "223-233",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF98": {
            "title": "Angiotensin 1\u20137 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Marcus",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Diabetes",
            "volume": "62",
            "issn": "",
            "pages": "1121-1130",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF99": {
            "title": "Increased circulating angiotensin-(1\u20137) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet",
            "authors": [
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Regul. Pept.",
            "volume": "178",
            "issn": "",
            "pages": "64-70",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF100": {
            "title": "Adenoviral delivery of angiotensin-(1\u20137) or angiotensin-(1\u20139) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Flores-Munoz",
                    "suffix": ""
                },
                {
                    "first": "BM",
                    "middle": [],
                    "last": "Godinho",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Almalik",
                    "suffix": ""
                },
                {
                    "first": "SA",
                    "middle": [],
                    "last": "Nicklin",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "PLoS ONE",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF101": {
            "title": "Oral administration of angiotensin-(1\u20137) ameliorates type 2 diabetes in rats",
            "authors": [
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J. Mol. Med. (Berl.)",
            "volume": "92",
            "issn": "",
            "pages": "255-265",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF102": {
            "title": "The renin angiotensin aldosterone system and insulin resistance in humans",
            "authors": [
                {
                    "first": "PC",
                    "middle": [],
                    "last": "Underwood",
                    "suffix": ""
                },
                {
                    "first": "GK",
                    "middle": [],
                    "last": "Adler",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Curr. Hypertens. Rep.",
            "volume": "15",
            "issn": "",
            "pages": "59-70",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF103": {
            "title": "Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Andreozzi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Laratta",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sciacqua",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Perticone",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Sesti",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Circ. Res.",
            "volume": "94",
            "issn": "",
            "pages": "1211-1218",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF104": {
            "title": "Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease",
            "authors": [
                {
                    "first": "HN",
                    "middle": [],
                    "last": "Reich",
                    "suffix": ""
                },
                {
                    "first": "GY",
                    "middle": [],
                    "last": "Oudit",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Penninger",
                    "suffix": ""
                },
                {
                    "first": "JW",
                    "middle": [],
                    "last": "Scholey",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Herzenberg",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Kidney Int.",
            "volume": "74",
            "issn": "",
            "pages": "1610-1616",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF105": {
            "title": "Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J. Am. Soc. Nephrol.",
            "volume": "17",
            "issn": "",
            "pages": "3067-3075",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF106": {
            "title": "Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mizuiri",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am. J. Kidney Dis.",
            "volume": "51",
            "issn": "",
            "pages": "613-623",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF107": {
            "title": "Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury",
            "authors": [
                {
                    "first": "DW",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Am. J. Pathol.",
            "volume": "171",
            "issn": "",
            "pages": "438-451",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF108": {
            "title": "Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shiota",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Hypertens. Res.",
            "volume": "33",
            "issn": "",
            "pages": "298-307",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF109": {
            "title": "Human recombinant ACE2 reduces the progression of diabetic nephropathy",
            "authors": [
                {
                    "first": "GY",
                    "middle": [],
                    "last": "Oudit",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Diabetes",
            "volume": "59",
            "issn": "",
            "pages": "529-538",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF110": {
            "title": "Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition",
            "authors": [
                {
                    "first": "CX",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Mol. Med.",
            "volume": "17",
            "issn": "",
            "pages": "59-69",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF111": {
            "title": "Targeting the renin-angiotensin-aldosterone system in heart failure",
            "authors": [
                {
                    "first": "CC",
                    "middle": [],
                    "last": "Lang",
                    "suffix": ""
                },
                {
                    "first": "AD",
                    "middle": [],
                    "last": "Struthers",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nat. Rev. Cardiol.",
            "volume": "10",
            "issn": "",
            "pages": "125-134",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF112": {
            "title": "Angiotensin-(1\u20139) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Flores-Munoz",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Hypertension",
            "volume": "59",
            "issn": "",
            "pages": "300-307",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF113": {
            "title": "Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Nadarajah",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Kidney Int.",
            "volume": "82",
            "issn": "",
            "pages": "292-303",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF114": {
            "title": "Angiotensin-(1\u20137) attenuates diabetic nephropathy in Zucker diabetic fatty rats",
            "authors": [
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Giani",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Am. J. Physiol. Renal Physiol.",
            "volume": "302",
            "issn": "",
            "pages": "F1606-F1615",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF115": {
            "title": "Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gembardt",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Peptides",
            "volume": "26",
            "issn": "",
            "pages": "1270-1277",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF116": {
            "title": "ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hashimoto",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Nature",
            "volume": "487",
            "issn": "",
            "pages": "477-481",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF117": {
            "title": "Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Nature",
            "volume": "472",
            "issn": "",
            "pages": "57-63",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF118": {
            "title": "Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Haschke",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Clin. Pharmacokinet",
            "volume": "52",
            "issn": "",
            "pages": "783-792",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF119": {
            "title": "Phase I/II dose escalation study of angiotensin 1\u20137 [A(1\u20137)] administered before and after chemotherapy in patients with newly diagnosed breast cancer",
            "authors": [
                {
                    "first": "KE",
                    "middle": [],
                    "last": "Rodgers",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Oliver",
                    "suffix": ""
                },
                {
                    "first": "GS",
                    "middle": [],
                    "last": "diZerega",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Cancer Chemother. Pharmacol.",
            "volume": "57",
            "issn": "",
            "pages": "559-568",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF120": {
            "title": "Effect of angiotensin-(1\u20137) and bradykinin in patients with heart failure treated with an ACE inhibitor",
            "authors": [
                {
                    "first": "AP",
                    "middle": [],
                    "last": "Davie",
                    "suffix": ""
                },
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "McMurray",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Hypertension",
            "volume": "34",
            "issn": "",
            "pages": "457-460",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF121": {
            "title": "Angiotensin-(1\u20137) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1\u20137) analog",
            "authors": [
                {
                    "first": "LD",
                    "middle": [],
                    "last": "Kluskens",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J. Pharmacol. Exp. Ther.",
            "volume": "328",
            "issn": "",
            "pages": "849-854",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF122": {
            "title": "Oral and pulmonary delivery of thioether-bridged angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "de Vries",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Peptides",
            "volume": "31",
            "issn": "",
            "pages": "893-898",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF123": {
            "title": "Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)",
            "authors": [
                {
                    "first": "DW",
                    "middle": [],
                    "last": "Lambert",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J. Biol. Chem.",
            "volume": "280",
            "issn": "",
            "pages": "30113-30119",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF124": {
            "title": "The effect of the thioether-bridged, stabilized angiotensin-(1\u20137) analogue cyclic ang-(1\u20137) on cardiac remodeling and endothelial function in rats with myocardial infarction",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Durik",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Int. J. Hypertens.",
            "volume": "2012",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF125": {
            "title": "An oral formulation of angiotensin-(1\u20137) produces cardioprotective effects in infarcted and isoproterenol-treated rats",
            "authors": [
                {
                    "first": "FD",
                    "middle": [],
                    "last": "Marques",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Hypertension",
            "volume": "57",
            "issn": "",
            "pages": "477-483",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF126": {
            "title": "Beneficial effects of long-term administration of an oral formulation of angiotensin-(1\u20137) in infarcted rats",
            "authors": [
                {
                    "first": "FD",
                    "middle": [],
                    "last": "Marques",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Int. J. Hypertens.",
            "volume": "2012",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF127": {
            "title": "Oral formulation of angiotensin-(1\u20137) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice",
            "authors": [
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Feltenberger",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Hypertension",
            "volume": "62",
            "issn": "",
            "pages": "324-330",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF128": {
            "title": "Angiotensin-(1\u20137): beyond the cardio-renal actions",
            "authors": [
                {
                    "first": "DG",
                    "middle": [],
                    "last": "Passos-Silva",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Verano-Braga",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Clin. Sci. (Lond.)",
            "volume": "124",
            "issn": "",
            "pages": "443-456",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF129": {
            "title": "ACE2-angiotensin-(1\u20137)-Mas axis and oxidative stress in cardiovascular disease",
            "authors": [
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Rabelo",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Alenina",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bader",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Hypertens. Res.",
            "volume": "34",
            "issn": "",
            "pages": "154-160",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF130": {
            "title": "ACE2, angiotensin-(1\u20137) and Mas receptor axis in inflammation and fibrosis",
            "authors": [
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Simoes e Silva",
                    "suffix": ""
                },
                {
                    "first": "KD",
                    "middle": [],
                    "last": "Silveira",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                },
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Teixeira",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Br. J. Pharmacol.",
            "volume": "169",
            "issn": "",
            "pages": "477-492",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF131": {
            "title": "Angiotensin-converting enzyme 2: central regulator for cardiovascular function",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lazartigues",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Curr. Hypertens. Rep.",
            "volume": "12",
            "issn": "",
            "pages": "170-175",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF132": {
            "title": "Therapeutic targeting of the angiotensin-converting enzyme 2/angiotensin-(1\u20137)/Mas cascade in the renin-angiotensin system: a patent review",
            "authors": [
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bader",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Expert Opin. Ther. Pat.",
            "volume": "22",
            "issn": "",
            "pages": "567-574",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF133": {
            "title": "Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor \u03b1-converting enzyme",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Iwata",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Silva Enciso",
                    "suffix": ""
                },
                {
                    "first": "BH",
                    "middle": [],
                    "last": "Greenberg",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Am. J. Physiol. Cell Physiol.",
            "volume": "297",
            "issn": "",
            "pages": "C1318-C1329",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF134": {
            "title": "Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Epelman",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J. Am. Coll. Cardiol.",
            "volume": "52",
            "issn": "",
            "pages": "750-754",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF135": {
            "title": "Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Epelman",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J. Card Fail",
            "volume": "15",
            "issn": "",
            "pages": "565-571",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF136": {
            "title": "Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study",
            "authors": [
                {
                    "first": "JT",
                    "middle": [],
                    "last": "Ortiz-Perez",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PLoS ONE",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF137": {
            "title": "Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS",
            "authors": [
                {
                    "first": "VB",
                    "middle": [],
                    "last": "Patel",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J. Mol. Cell Cardiol.",
            "volume": "66",
            "issn": "",
            "pages": "167-176",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF138": {
            "title": "Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors",
            "authors": [
                {
                    "first": "NA",
                    "middle": [],
                    "last": "Dales",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J. Am. Chem. Soc.",
            "volume": "124",
            "issn": "",
            "pages": "11852-11853",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF139": {
            "title": "ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Towler",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J. Biol. Chem.",
            "volume": "279",
            "issn": "",
            "pages": "17996-18007",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF140": {
            "title": "ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Soler",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Kidney Int.",
            "volume": "72",
            "issn": "",
            "pages": "614-623",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF141": {
            "title": "A new look at the renin-angiotensin system\u2014focusing on the vascular system",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nguyen Dinh Cat",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Touyz",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Peptides",
            "volume": "32",
            "issn": "",
            "pages": "2141-2150",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF142": {
            "title": "Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats",
            "authors": [
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Trask",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am. J. Hypertens.",
            "volume": "23",
            "issn": "",
            "pages": "687-693",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF143": {
            "title": "Novel peptide inhibitors of angiotensin-converting enzyme 2",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J. Biol. Chem.",
            "volume": "278",
            "issn": "",
            "pages": "15532-15540",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF144": {
            "title": "Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1\u20137/Mas axis",
            "authors": [
                {
                    "first": "BD",
                    "middle": [],
                    "last": "Uhal",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abdul-Hafez",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Am. J. Physiol. Lung Cell. Mol. Physiol.",
            "volume": "301",
            "issn": "",
            "pages": "L269-L274",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF145": {
            "title": "ACE2 activation promotes antithrombotic activity",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Fraga-Silva",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Mol. Med.",
            "volume": "16",
            "issn": "",
            "pages": "210-215",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF146": {
            "title": "Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays",
            "authors": [
                {
                    "first": "KB",
                    "middle": [],
                    "last": "Pedersen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sriramula",
                    "suffix": ""
                },
                {
                    "first": "KH",
                    "middle": [],
                    "last": "Chhabra",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lazartigues",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Am. J. Physiol. Regul. Integr. Comp. Physiol.",
            "volume": "301",
            "issn": "",
            "pages": "R1293-R1299",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF147": {
            "title": "Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Hypertension",
            "volume": "60",
            "issn": "",
            "pages": "730-740",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF148": {
            "title": "Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Hern\u00e1ndez Prada",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Hypertension",
            "volume": "51",
            "issn": "",
            "pages": "1312-1317",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF149": {
            "title": "Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases",
            "authors": [
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Exp. Physiol.",
            "volume": "96",
            "issn": "",
            "pages": "287-294",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF150": {
            "title": "Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro",
            "authors": [
                {
                    "first": "PK",
                    "middle": [],
                    "last": "Haber",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Hypertension",
            "volume": "63",
            "issn": "",
            "pages": "774-782",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF151": {
            "title": "Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation",
            "authors": [
                {
                    "first": "DJ",
                    "middle": [],
                    "last": "Campbell",
                    "suffix": ""
                },
                {
                    "first": "CJ",
                    "middle": [],
                    "last": "Zeitz",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Esler",
                    "suffix": ""
                },
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Horowitz",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J. Hypertens.",
            "volume": "22",
            "issn": "",
            "pages": "1971-1976",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF152": {
            "title": "Renin-angiotensin system blockade and cardiovascular and renal protection",
            "authors": [
                {
                    "first": "BJ",
                    "middle": [],
                    "last": "Hoogwerf",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am. J. Cardiol.",
            "volume": "105",
            "issn": "",
            "pages": "30A-35A",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF153": {
            "title": "Phase I and pharmacokinetic study of angiotensin-(1\u20137), an endogenous antiangiogenic hormone",
            "authors": [
                {
                    "first": "WJ",
                    "middle": [],
                    "last": "Petty",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Clin. Cancer Res.",
            "volume": "15",
            "issn": "",
            "pages": "7398-7404",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF154": {
            "title": "Converting enzyme determines plasma clearance of angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yamada",
                    "suffix": ""
                },
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Iyer",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Chappell",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ganten",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Hypertension",
            "volume": "32",
            "issn": "",
            "pages": "496-502",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF155": {
            "title": "Pathways for angiotensin-(1\u20137) metabolism in pulmonary and renal tissues",
            "authors": [
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Allred",
                    "suffix": ""
                },
                {
                    "first": "DI",
                    "middle": [],
                    "last": "Diz",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Chappell",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Am. J. Physiol. Renal Physiol.",
            "volume": "279",
            "issn": "",
            "pages": "F841-F850",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF156": {
            "title": "Angiotensin-(1\u20137): pharmacological properties and pharmacotherapeutic perspectives",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Iusuf",
                    "suffix": ""
                },
                {
                    "first": "RH",
                    "middle": [],
                    "last": "Henning",
                    "suffix": ""
                },
                {
                    "first": "WH",
                    "middle": [],
                    "last": "van Gilst",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Roks",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Eur. J. Pharmacol.",
            "volume": "585",
            "issn": "",
            "pages": "303-312",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF157": {
            "title": "Angiotensin-(1\u20137) in kidney disease: a review of the controversies",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zimmerman",
                    "suffix": ""
                },
                {
                    "first": "KD",
                    "middle": [],
                    "last": "Burns",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Clin. Sci. (Lond.)",
            "volume": "123",
            "issn": "",
            "pages": "333-346",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF158": {
            "title": "Chronic infusion of angiotensin-(1\u20137) improves insulin resistance and hypertension induced by a high-fructose diet in rats",
            "authors": [
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Giani",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Am. J. Physiol. Endocrinol. Metab.",
            "volume": "296",
            "issn": "",
            "pages": "E262-E271",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF159": {
            "title": "Angiotensin 1\u20137 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Echeverria-Rodriguez",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Del Valle-Mondragon",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Peptides",
            "volume": "51",
            "issn": "",
            "pages": "26-30",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF160": {
            "title": "Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Arterioscler. Thromb. Vasc. Biol.",
            "volume": "30",
            "issn": "",
            "pages": "953-961",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF161": {
            "title": "Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Donoghue",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J. Mol. Cell Cardiol.",
            "volume": "35",
            "issn": "",
            "pages": "1043-1053",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF162": {
            "title": "Effect of angiotensin-(1\u20137) on reperfusion arrhythmias in isolated rat hearts",
            "authors": [
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Neves",
                    "suffix": ""
                },
                {
                    "first": "AP",
                    "middle": [],
                    "last": "Almeida",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Khosla",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Campagnole-Santos",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Braz. J. Med. Biol. Res.",
            "volume": "30",
            "issn": "",
            "pages": "801-809",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF163": {
            "title": "Renin-angiotensin system: upgrade of recent knowledge and perspectives",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Herichova",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Szantoova",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Endocr. Regul.",
            "volume": "47",
            "issn": "",
            "pages": "39-52",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF164": {
            "title": "Beneficial versus harmful effects of angiotensin (1\u20137) on impulse propagation and cardiac arrhythmias in the failing heart",
            "authors": [
                {
                    "first": "WC",
                    "middle": [],
                    "last": "De Mello",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Jessup",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J. Renin Angiotensin Aldosterone Syst.",
            "volume": "8",
            "issn": "",
            "pages": "74-80",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF165": {
            "title": "Molecular mechanisms involved in the angiotensin-(1\u20137)/Mas signaling pathway in cardiomyocytes",
            "authors": [
                {
                    "first": "MF",
                    "middle": [],
                    "last": "Dias-Peixoto",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Hypertension",
            "volume": "52",
            "issn": "",
            "pages": "542-548",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF166": {
            "title": "Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors",
            "authors": [
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Giani",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "293",
            "issn": "",
            "pages": "H1154-H1163",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF167": {
            "title": "Angiotensin-(1\u20137) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways",
            "authors": [
                {
                    "first": "WO",
                    "middle": [],
                    "last": "Sampaio",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Hypertension",
            "volume": "49",
            "issn": "",
            "pages": "185-192",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF168": {
            "title": "Control of adipogenesis by the autocrine interplays between angiotensin 1\u20137/Mas receptor and angiotensin II/AT1 receptor signaling pathways",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Than",
                    "suffix": ""
                },
                {
                    "first": "MK",
                    "middle": [],
                    "last": "Leow",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J. Biol. Chem.",
            "volume": "288",
            "issn": "",
            "pages": "15520-15531",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF169": {
            "title": "Angiotensin-(1\u20137) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas",
            "authors": [
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Munoz",
                    "suffix": ""
                },
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Giani",
                    "suffix": ""
                },
                {
                    "first": "FP",
                    "middle": [],
                    "last": "Dominici",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Regul. Pept.",
            "volume": "161",
            "issn": "",
            "pages": "1-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF170": {
            "title": "Angiotensin-(1\u20137) counterregulates angiotensin II signaling in human endothelial cells",
            "authors": [
                {
                    "first": "WO",
                    "middle": [],
                    "last": "Sampaio",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Henrique de Castro",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                },
                {
                    "first": "EL",
                    "middle": [],
                    "last": "Schiffrin",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Touyz",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Hypertension",
            "volume": "50",
            "issn": "",
            "pages": "1093-1098",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF171": {
            "title": "Molecular mechanisms of inhibition of vascular growth by angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Tallant",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Hypertension",
            "volume": "42",
            "issn": "",
            "pages": "574-579",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF172": {
            "title": "Different effects of angiotensin II and angiotensin-(1\u20137) on vascular smooth muscle cell proliferation and migration",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "PLoS ONE",
            "volume": "5",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF173": {
            "title": "Angiotensin-(1\u20137) inhibits growth of cardiac myocytes through activation of the mas receptor",
            "authors": [
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Tallant",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "PE",
                    "middle": [],
                    "last": "Gallagher",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "289",
            "issn": "",
            "pages": "H1560-H1566",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF174": {
            "title": "On the local cardiac renin angiotensin system. Basic and clinical implications",
            "authors": [
                {
                    "first": "WC",
                    "middle": [],
                    "last": "De Mello",
                    "suffix": ""
                },
                {
                    "first": "ED",
                    "middle": [],
                    "last": "Frohlich",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Peptides",
            "volume": "32",
            "issn": "",
            "pages": "1774-1779",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF175": {
            "title": "Angiotensin-(1\u20137) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zimpelmann",
                    "suffix": ""
                },
                {
                    "first": "KD",
                    "middle": [],
                    "last": "Burns",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Kidney Int.",
            "volume": "69",
            "issn": "",
            "pages": "2212-2218",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF176": {
            "title": "Angiotensin-(1\u20137) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Nie",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Mol. Immunol.",
            "volume": "46",
            "issn": "",
            "pages": "355-361",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF177": {
            "title": "Angiotensin-(1\u20137) activates growth-stimulatory pathways in human mesangial cells",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zimpelmann",
                    "suffix": ""
                },
                {
                    "first": "KD",
                    "middle": [],
                    "last": "Burns",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Am. J. Physiol. Renal Physiol.",
            "volume": "296",
            "issn": "",
            "pages": "F337-F346",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF178": {
            "title": "Angiotensin-(1\u20137)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells",
            "authors": [
                {
                    "first": "GC",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "GY",
                    "middle": [],
                    "last": "Oudit",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "JW",
                    "middle": [],
                    "last": "Scholey",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Am. J. Physiol. Renal Physiol.",
            "volume": "302",
            "issn": "",
            "pages": "F784-F790",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF179": {
            "title": "Angiotensin (1\u20137) increases the potassium current and the resting potential of arterial myocytes from vascular resistance vessels of normal adult rats: pathophysiological implications",
            "authors": [
                {
                    "first": "WC",
                    "middle": [],
                    "last": "De Mello",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J. Am. Soc. Hypertens.",
            "volume": "8",
            "issn": "",
            "pages": "14-20",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF180": {
            "title": "Angiotensin-(1\u20137) binding at angiotensin II receptors in the rat brain",
            "authors": [
                {
                    "first": "BP",
                    "middle": [],
                    "last": "Rowe",
                    "suffix": ""
                },
                {
                    "first": "DL",
                    "middle": [],
                    "last": "Saylor",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Speth",
                    "suffix": ""
                },
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Absher",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Regul. Pept.",
            "volume": "56",
            "issn": "",
            "pages": "139-146",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF181": {
            "title": "Angiotensin-(1\u20137) binds at the type 1 angiotensin II receptors in rat renal cortex",
            "authors": [
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Gironacci",
                    "suffix": ""
                },
                {
                    "first": "MP",
                    "middle": [],
                    "last": "Coba",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pena",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Regul. Pept.",
            "volume": "84",
            "issn": "",
            "pages": "51-54",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF182": {
            "title": "Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bosnyak",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Clin. Sci. (Lond.)",
            "volume": "121",
            "issn": "",
            "pages": "297-303",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF183": {
            "title": "Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1\u20137)",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lara Lda",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Biochem. J.",
            "volume": "395",
            "issn": "",
            "pages": "183-190",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF184": {
            "title": "Angiotensin-(1\u20137) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats",
            "authors": [
                {
                    "first": "PE",
                    "middle": [],
                    "last": "Walters",
                    "suffix": ""
                },
                {
                    "first": "TA",
                    "middle": [],
                    "last": "Gaspari",
                    "suffix": ""
                },
                {
                    "first": "RE",
                    "middle": [],
                    "last": "Widdop",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Hypertension",
            "volume": "45",
            "issn": "",
            "pages": "960-966",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF185": {
            "title": "ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bader",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Pflugers Arch.",
            "volume": "465",
            "issn": "",
            "pages": "79-85",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF186": {
            "title": "Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Young",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Waitches",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Birchmeier",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Fasano",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wigler",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "Cell",
            "volume": "45",
            "issn": "",
            "pages": "711-719",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF187": {
            "title": "Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "100",
            "issn": "",
            "pages": "8258-8263",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF188": {
            "title": "Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Metzger",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "FEBS Lett.",
            "volume": "357",
            "issn": "",
            "pages": "27-32",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF189": {
            "title": "Genetically altered animal models for Mas and angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Alenina",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rentzsch",
                    "suffix": ""
                },
                {
                    "first": "EL",
                    "middle": [],
                    "last": "Patkin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bader",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Exp. Physiol.",
            "volume": "93",
            "issn": "",
            "pages": "528-537",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF190": {
            "title": "Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Young",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "O'Neill",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Jessell",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wigler",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Proc. Natl Acad. Sci. USA",
            "volume": "85",
            "issn": "",
            "pages": "5339-5342",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF191": {
            "title": "Impairment of in vitro and in vivo heart function in angiotensin-(1\u20137) receptor MAS knockout mice",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hypertension",
            "volume": "47",
            "issn": "",
            "pages": "996-1002",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF192": {
            "title": "Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1\u20137) in heart and kidney of spontaneously hypertensive rats",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J. Renin Angiotensin Aldosterone Syst.",
            "volume": "12",
            "issn": "",
            "pages": "413-419",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF193": {
            "title": "The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli",
            "authors": [
                {
                    "first": "MF",
                    "middle": [],
                    "last": "Dias-Peixoto",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Peptides",
            "volume": "35",
            "issn": "",
            "pages": "196-201",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF194": {
            "title": "Selective expression of c-mas proto-oncogene in rat cerebral endothelial cells",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Grammas",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Giacomelli",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wiener",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Neuroreport",
            "volume": "8",
            "issn": "",
            "pages": "93-96",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF195": {
            "title": "Signal transduction mechanisms involved in angiotensin-(1\u20137)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells",
            "authors": [
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Muthalif",
                    "suffix": ""
                },
                {
                    "first": "IF",
                    "middle": [],
                    "last": "Benter",
                    "suffix": ""
                },
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Uddin",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Harper",
                    "suffix": ""
                },
                {
                    "first": "KU",
                    "middle": [],
                    "last": "Malik",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J. Pharmacol. Exp. Ther.",
            "volume": "284",
            "issn": "",
            "pages": "388-398",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF196": {
            "title": "A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Donoghue",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Circ. Res.",
            "volume": "87",
            "issn": "",
            "pages": "E1-E9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF197": {
            "title": "Angiotensin-(1\u20137) inhibits vascular smooth muscle cell growth",
            "authors": [
                {
                    "first": "EJ",
                    "middle": [],
                    "last": "Freeman",
                    "suffix": ""
                },
                {
                    "first": "GM",
                    "middle": [],
                    "last": "Chisolm",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Tallant",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Hypertension",
            "volume": "28",
            "issn": "",
            "pages": "104-108",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF198": {
            "title": "Ablation of angiotensin (1\u20137) receptor Mas in C57Bl/6 mice causes endothelial dysfunction",
            "authors": [
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Rabelo",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J. Am. Soc. Hypertens.",
            "volume": "2",
            "issn": "",
            "pages": "418-424",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF199": {
            "title": "Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Peir\u00f3",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J. Hypertens.",
            "volume": "25",
            "issn": "",
            "pages": "2421-2425",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF200": {
            "title": "Genetic deletion of the angiotensin-(1\u20137) receptor Mas leads to glomerular hyperfiltration and microalbuminuria",
            "authors": [
                {
                    "first": "SV",
                    "middle": [],
                    "last": "Pinheiro",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Kidney Int.",
            "volume": "75",
            "issn": "",
            "pages": "1184-1193",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF201": {
            "title": "Knockout of angiotensin 1\u20137 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Rakusan",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Kidney Blood Press Res.",
            "volume": "33",
            "issn": "",
            "pages": "476-488",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF202": {
            "title": "The genetic deletion of Mas abolishes salt induced hypertension in mice",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Heringer-Walther",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Eur. J. Pharmacol.",
            "volume": "689",
            "issn": "",
            "pages": "147-153",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF203": {
            "title": "ACE2/ANG-(1\u20137)/Mas pathway in the brain: the axis of good",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sriramula",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lazartigues",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Am. J. Physiol. Regul. Integr. Comp. Physiol.",
            "volume": "300",
            "issn": "",
            "pages": "R804-R817",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF204": {
            "title": "The ANG-(1\u20137)/ACE2/mas axis in the regulation of nephron function",
            "authors": [
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Varagic",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am. J. Physiol. Renal Physiol.",
            "volume": "298",
            "issn": "",
            "pages": "F1297-F1305",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF205": {
            "title": "Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1\u20137)-Mas receptor axis",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Iwai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Horiuchi",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Hypertens. Res.",
            "volume": "32",
            "issn": "",
            "pages": "533-536",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF206": {
            "title": "Mas oncogene signaling and transformation require the small GTP-binding protein Rac",
            "authors": [
                {
                    "first": "IE",
                    "middle": [],
                    "last": "Zohn",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Symons",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chrzanowska-Wodnicka",
                    "suffix": ""
                },
                {
                    "first": "JK",
                    "middle": [],
                    "last": "Westwick",
                    "suffix": ""
                },
                {
                    "first": "CJ",
                    "middle": [],
                    "last": "Der",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Mol. Cell Biol.",
            "volume": "18",
            "issn": "",
            "pages": "1225-1235",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF207": {
            "title": "A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase",
            "authors": [
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Tipnis",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J. Biol. Chem.",
            "volume": "275",
            "issn": "",
            "pages": "33238-33243",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF208": {
            "title": "Inhibition of human lung cancer cell growth by angiotensin-(1\u20137)",
            "authors": [
                {
                    "first": "PE",
                    "middle": [],
                    "last": "Gallagher",
                    "suffix": ""
                },
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Tallant",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Carcinogenesis",
            "volume": "25",
            "issn": "",
            "pages": "2045-2052",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF209": {
            "title": "Angiotensin-(1\u20137) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Krishnan",
                    "suffix": ""
                },
                {
                    "first": "FM",
                    "middle": [],
                    "last": "Torti",
                    "suffix": ""
                },
                {
                    "first": "PE",
                    "middle": [],
                    "last": "Gallagher",
                    "suffix": ""
                },
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Tallant",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Prostate",
            "volume": "73",
            "issn": "",
            "pages": "60-70",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF210": {
            "title": "Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Canals",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jenkins",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kellett",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Milligan",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J. Biol. Chem.",
            "volume": "281",
            "issn": "",
            "pages": "16757-16767",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF211": {
            "title": "Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Am. J. Physiol. Heart Circ. Physiol.",
            "volume": "302",
            "issn": "",
            "pages": "H299-H311",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF212": {
            "title": "Effects of angiotensin IV and angiotensin-(1\u20137) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chansel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Vandermeersch",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Oko",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Curat",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ardaillou",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Eur. J. Pharmacol.",
            "volume": "414",
            "issn": "",
            "pages": "165-175",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF213": {
            "title": "Angiotensin-(1\u20137): a new hormone of the angiotensin system",
            "authors": [
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Hypertension",
            "volume": "18",
            "issn": "",
            "pages": "III126-III133",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF214": {
            "title": "Angiotensin (1\u20137) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs",
            "authors": [
                {
                    "first": "EJ",
                    "middle": [],
                    "last": "Tassone",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Cardiovasc. Res.",
            "volume": "99",
            "issn": "",
            "pages": "129-136",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF215": {
            "title": "G.-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kostenis",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Circulation",
            "volume": "111",
            "issn": "",
            "pages": "1806-1813",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF216": {
            "title": "International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands",
            "authors": [
                {
                    "first": "AP",
                    "middle": [],
                    "last": "Davenport",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Pharmacol. Rev.",
            "volume": "65",
            "issn": "",
            "pages": "967-986",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF217": {
            "title": "Characterization of a new angiotensin antagonist selective for angiotensin-(1\u20137): evidence that the actions of angiotensin-(1\u20137) are mediated by specific angiotensin receptors",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Brain Res. Bull.",
            "volume": "35",
            "issn": "",
            "pages": "293-298",
            "other_ids": {
                "DOI": []
            }
        }
    }
}